Development and Applications of Mass Spectrometric Methods for Phosphorylation Analysis by Ho, Hsin-Pin
City University of New York (CUNY)
CUNY Academic Works
Dissertations, Theses, and Capstone Projects Graduate Center
10-2014
Development and Applications of Mass
Spectrometric Methods for Phosphorylation
Analysis
Hsin-Pin Ho
Graduate Center, City University of New York
How does access to this work benefit you? Let us know!
Follow this and additional works at: https://academicworks.cuny.edu/gc_etds
Part of the Chemistry Commons
This Dissertation is brought to you by CUNY Academic Works. It has been accepted for inclusion in All Dissertations, Theses, and Capstone Projects
by an authorized administrator of CUNY Academic Works. For more information, please contact deposit@gc.cuny.edu.
Recommended Citation
Ho, Hsin-Pin, "Development and Applications of Mass Spectrometric Methods for Phosphorylation Analysis" (2014). CUNY
Academic Works.
https://academicworks.cuny.edu/gc_etds/432
DOCTORAL DISSERTATION 
 
 
 
 
 
 
 
 
 
 
 DEVELOPMENT AND APPLICATIONS OF MASS 
SPECTROMETRIC METHODS FOR PHOSPHORYLATION 
ANALYSIS 
 
by 
 
Hsin-Pin Ho 
 
 
 
 
 
 
 
A dissertation submitted to the Graduate Faculty in Chemistry in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy, The City University of New York  
2014 
 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
@2014 
HSIN-PIN HO 
All Rights Reserved 
 iii 
Approval Page 
 
 
 
 
This manuscript has been read and accepted for the Graduate Faculty in Chemistry in satisfaction of 
the dissertation requirement for the degree of Doctor of Philosophy. 
 
 
 
 
 
 
 
    09/14/2014   Dr. Emmanuel J. Chang   
 
Date  Chair of Examining Committee 
 
 
    09/16/2014   Dr. Brian Gibney   
 
Date  Executive Officer 
 
 
 
 
 
 
  Dr. Amy Ikui  
  Dr. Yi He  
  Dr. Adam Profit  
Supervisory Committee 
 
 
 
 
THE CITY UNIVERSITY OF NEW YORK 
 
 iv 
Abstract 
Development and Applications of Mass Spectrometric Methods for Phosphorylation Analysis 
by 
Hsin-Pin Ho 
Advisor: Dr. Emmanuel J. Chang 
 Protein phosphorylation modification regulates numerous cellular functions by a reversible 
and selective control of kinases and phosphatases. To understand the entire dynamic network of 
phosphorylation requires sensitive and reliable quantification of phosphorylation, measurements that 
can be achieved by mass spectrometry. In this research, we established efficient MALDI-mass 
spectrometric methods as strategies for single- or multi-site phosphorylation quantification without 
the use of isotopes, chromatography and calibration curves. The methods were assessed by 
analyzing peptide standards with different single-multiple phosphorylation sites, showing a wide 
dynamic range, good accuracy and reproducibility. This is the first label-free MALDI method 
without using a calibration methodology proposed for quantification of in vitro phosphorylation in a 
kinase assay.   
Moreover, advanced mass spectrometry empowers identification of a highly conserved Cdk2 
phosphorylation site of HIV-1 reverse transcriptase (RT) at Thr 261 across thousands of HIV-1 
strains. We demonstrated phosphorylation on HIV-1 RT peptides and protein in in vitro assays, and 
confirmed phosphorylation in vivo with antibodies and mutation studies. Blocking this 
phosphorylation by p21, a naturally occurring Cdk inhibitor, defines a potential Cdk2-mediated cell-
intrinsic mechanism for restricting HIV-replication in a clinically significant way. 
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Chapter 1: Introduction to Protein Phosphorylation and Mass Spectrometry 
1.1 Objectives and rationale of the study 
1.2 Protein phosphorylation 
1.2.1 Cdk phosphorylation 
1.2.2 Specific examples of phosphorylated Cdk substrates 
1.3 Mass spectrometry 
1.3.1 Desorption Ionization 
1.3.2 Mass analyzer 
1.3.3 MS techniques applied to this thesis – MALDI-LIT MS 
1.3.4 Tandem Mass spectrometry (MS/MS) 
1.4 Protein identification and phosphorylation analysis in MS 
1.4.1 MS protein identification approaches 
1.4.2 Phosphorylation analysis in MS 
1.4.3 MS-based quantitative analysis 
 
1.1 Objectives and rationale of the study  
 The objectives of this study are to develop label-free mass spectrometric methods for 
quantification of single or double-site phosphorylation (chapter 2), and to investigate Cdk (cyclin-
dependent kinase) phosphoryaiton in HIV-1 reverse transcriptase (RT) by mass spectrometry-based 
techniques (chapter 3). The organization of the dissertation is described below. 
 This chapter introduces the background of Cdk phosphorylation and gives specific examples 
of phosphorylated Cdk substrates. The following text depicts essential parts of an analytical 
biological mass spectrometers (including desorption ionization and mass analyzers but emphasizing 
the techniques applied to this thesis), and the state-of-the-art in tandem mass spectrometry. The 
approaches of mass spectrometry are described instrumentally and methodically for protein 
phosphorylation identification and quantification. 
 In Chapter 2 includes two projects with a mutual goal - to develop label-free mass 
spectrometric strategies as alternatives for quantitative phosphoproteomics due to its low cost and 
convenience. The first project is to establish an efficient MALDI-mass spectrometric method, called 
Double Reciprocal Isotope-free Phosphopeptide Quantification (DRIP-Q), as the first proposed 
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isotope-free and calibration-curve-free MALDI-MS method for phosphorylation quantification. The 
results as follows include 1) a mathematic approach for phosphorylation quantification; 2) the effect 
of laser energy on phosphorylation quantification; 3) linearity, dynamic range and reproducibility; 4) 
validation of phosphorylation quantification by comparison with isotope dilution MALDI-MS; 5) 
applications to Cdk inhibition. 
 The second project in Chapter 2 is to utilize high sensitivity and specificity of MS3 to 
determine double-site phosphorylation of aquaporin, in which two different phosphorylation sites 
occur on Ser-256 and Ser-261 in response to vasopressin-dependent short-term regulation (2006 
Hoffert, 2010 Xie). The MS3 method proposed overcomes the difficulties in isomeric 
phosphopeptide stoichiometric analysis by CID based MS/MS without the use of isotopes. The 
results obtained of 1) MS2 and MS3 analyses of AQP-2 peptides; 2) a mathematic approach by using 
MS3 fragmentation for double phosphorylation site quantification; 3) consistency of MS3 fragment 
ratios; 4) the effect of collision energy on quantification; 5) quantitative dynamic range; and 6) 
applications to in vitro kinase assay will be discussed. 
 In Chapter 3, the project (in collaboration with Mathias Litchterfeld’s group at 
Massachusetts General Hospital) uncovered a cell-intrinsic mechanism of HIV-1 reverse 
transcription associated with Cdk2 phosphorylation. The results strongly suggest that p21 indirectly 
blocks HIV-1 reverse transcription by inhibiting Cdk2-dependent phosphorylation of RT, including 
the following parts: 1) Host Cdks support HIV-1 reverse transcription in CD4+ T cells; 2) HIV-1 RT 
is a substrate for Cdk2-dependent phosphorylation; 3) substitution of T216 by Alanine reduces 
HIV-1 RT; 4) Quantification of HIV-1 in vitro Cdk2-dependent phosphorylation; 5) Cdk2-dependent 
phosphorylation increases function and stability of HIV-1 RT; 6) p21 suppresses Cdk2-dependent 
HIV-1 RT phosphorylation. 
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1.2 Protein Phosphorylation 
Most eukaryotic proteins selectively and specifically undergo covalent modification to 
regulate protein functions after being translated from mRNA (2005 Yang; 1995 Newton). 
Phosphorylation is one of the most important post-translational modifications in the human cells, 
occurring on serine/threonine/tyrosine residues in a number of proteins via catalytic addition of 
phosphate group from adenosine triphosphate (ATP) (2003 Mann). Protein phosphorylation is 
controlled by a wide variety of kinase and phosphatases, which themselves may be regulated by 
phosphorylation. Once a protein is phosphorylated by a kinase, the phosphorylation event can cause 
conformational and functional changes of the protein to either activate or de-activate the protein – 
an effective way to regulate protein functions (1993 Johnson). Here, we review the literature on Cdk 
phosphorylation, a very important post-translational modification in cellular regulation, and describe 
specific examples of Cdk phosphorylation substrates. 
1.2.1 CDK phosphorylation 
In the 1970s and 1980s, Cyclin-dependent kinases (Cdks), a family of serine/threonine 
protein kinases, were discovered as key regulators of the cell cycle in eukaryotic cells via 
phosphorylation by Hartwell, Hunt, and Nurse who were awarded the Nobel Prize in Physiology or 
Medicine for 2001 (1995 Morgan; 1989 Hartwell; 1989 Gould; 1983 Evans). Cdk complexes are 
composed of a Cdk catalytic subunit and a cyclin subunit, i.e. Cdk2/cyclin A. The activation of 
cyclin-Cdk complexes requires the binding of the cyclin subunit, phosphorylation activation on a 
conserved threonine (Thr160) in the Cdk activation loop by Cdk-activating kinase (CAK) (1995 
Morgan), and, in some cases (e.g. multisite phosphorylation), interaction with Cdc kinase subunit 
(Cks) protein (1996 Pines, 1996 Bourne, 2011 Balog). 
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Differences in cyclin-Cdk complexes give specificity of phosphorylation to particular 
substrates and sites in cells. For example, some cyclins contain a docking domain, a small 
hydrophobic patch for helping recruit their correct substrate to Cdks by interacting with an RXL 
motif on the specific substrates (2007 Ubersax, 2011 Kõivomägi).  A slight change in the sequences 
of the hydrophobic patches of different cyclins can lead to proper substrate recognition by either 
increasing local concentration of the kinase around the substrate, or orientating the substrate in the 
kinase active site, even though it still remains unclear if the Cdk complex binds to the RXL motif 
and the phosphorylation site on the substrate synchronously, especially for multiple phosphorylation 
sites on a substrate (2007 Ubersax).  
The Cdk’s sequences are complementary to the specific substrate’s sequences through 
hydrophobic interactions, charge-charge interactions or hydrogen bonding (1995 Jeffrey).  Cdks 
have a canonical catalytic domain composed of β-sheets in a small N-terminal lobe and α-helices 
in a larger C-terminal lobe. The ATP binding is found at a hydrophobic pocket between the two 
lobes where the adenosine moiety is buried with the phosphate backbone exposed to the solvent. 
The catalytic domain catalyzes the transfer of the terminal γ-phosphate moiety to the hydroxyl 
phosphorylation site on the substrate, which interacts to the kinase. The substrate consensus 
phosphorylation sites for Cdks 1, 2, 4, 5, and 6 (2010 Errico) are S/T-P-X-K/R, where S/T 
represents the phosphorylated residue, and X represents any amino acids followed by basic residues, 
K/R. The phosphorylated site “P” (S/T) is followed by a Pro residue, which contains a unique 
nitrogen atom among the 20 amino acids. Because the nitrogen atom is part of rigid pyrrolidone side 
chain ring; it cannot act as a hydrogen donor. Any other residue at P+1 is unfavorable owing to the 
existence of uncompensated hydrogen bonds from substrate to a main-chain nitrogen atom. The 
Pro residue at P+1 also constrain the conformation of the substrate, allowing a basic residue (K/R) 
at P+3 to interact with the phospho-Thr 160 in the kinase (1999 Brown). 
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Cks (cyclin-dependent kinase subunit), a subunit of Cdks, is a relatively small protein (9-18 
kDa), interacting with Cdk complexes in the control of cell cycle, has been identified since 1980’s; 
however researchers have long been tantalized by the implication of Cks for modulation of specific 
Cdk activity (1996 Pines) and their precise function still remains elusive. The crystal structures of the 
Cks proteins as a part of a complex with Cdks have been solved (1996 Bourne), suggesting Cks 
binds Cdks as a monomer, although Cks also exists as a dimer.  The exchange of the monomeric 
and dimeric states of Cks via its conserved β-hinge region regulates Cdks-Cks association and 
thereby regulates Cdk enzymatic activity (2006 Bader, 2001 Bousseau). Two highly conserved 
residues (Pro93 and Pro95) in the hinge region of Cks have been observed its role in tuning the 
dimerization equilibrium, and recently proposed to associate with formation of Cdk-Cks interface by 
stabilizing conformation for binding (2011 Balog). Besides, the structural data revealed a conserved 
cationic pocket that weakly binds to free phosphate as well as other anions, and interacts with the 
Cdk active site. Cks is considered as a phosphoadaptor subunit of the cyclin-Cdk-Cks complexes, 
positioning the kinase complex to phosphorylated substrates and promoting multiple 
phosphorylation, which occurs in clusters in majority of Cdk substrates (2013 Koivomagi). Cks 
binding sites have been predicted to preferentially occur in Cdk substrates that contain multiple 
phosphorylation sites, and more likely to be found in phosphorylated substrate on a Cdk consensus 
site (mostly Thr) nearby the phosphorylated Cdk consensus site (2013 McGrath).  
1.2.2 Specific examples of phosphorylated Cdk substrate 
Protein phosphorylation modification involves addition of phosphate to a protein. The 
bulky phosphate with a double negative charge, therefore, alters a protein’s physical and biochemical 
properties, and induces conformational changes that are responsible for the biological protein 
functions, such as activity, stability and interaction (2007 Singh; 2009 Li; 2010 Deribe). Several well-
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studied Cdk phosphorylation substrates involved in regulation of cell cycle and other biological 
processes have been reported. Some specific examples are introduced below. 
Sic1 acts as one of the important regulators through phosphorylation in cell cycle, a process 
of cell duplication and division, in Saccharomyces cerevisiae. The cell cycle is an ordered bio-event, 
including four phases, G1 phase (gap1, a growth phase for the cell) - S phase (DNA synthesis) - G2 
(gap2, a second growth phase for the next division) – M phase (mitosis, a process of cell division). 
Sic1 associates with Cdk1/cyclinB complexes to regulate the G1/S transition in yeast via proteolysis 
caused by phosphorylation as a part of the intrinsic cell cycle machinery. When Sic1 is 
unphosphorylated, the Cdk1/cyclinB stays inactive, whereas the inactive Cdk1 kinase complex is 
switched into active state by Sic1 degradation through its multiply phosphorylation by Cdk1 on the 
minimum six of nine Cdk consensus sites (1997 Verma, 1999 Hodge). One thing to note is that the 
multiple phosphorylation of Sic1 is stimulated by Cks in the early stage of phosphorylation, 
occurring after Cdk consensus site (T5 or T33) on Sic1 which is first phosphorylated by Cdk1. The 
phosphorylated T5 or T33 (Cks consensus sites) is recognized by Cks to induce multiple 
phosphorylation, allowing the binding of Cdc4, and consequently inducing Sic1 degradation. The 
Sic1 degradation is necessary for Cdk activation, leading to initiation of the following DNA 
synthesis (S phase) in the cell cycle (2011 Koivomagi).  
Schizosaccharomyces pombe Wee1 and Cdc25 (cell division cycle 25 homolog A) are, 
respectively, negative and positive regulators of Cdk1 protein kinase activation and localization 
during the G2/M transition. During the period of late S and G2 phase, cyclin B synthesis increases, 
promoting the binding of cyclin B to Cdk1. The Cdk1/cyclinB complexes are normally held in an 
inactive state as a result of phosphorylation of Cdk1 on Tyr15 by Wee1 (1994 Coleman, 1996 Lew, 
2007 Perry). Wee1 and Cdk1 show mutual regulation: Wee1 itself is first phosphorylated and 
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activated by Cdk1/cyclinB undergoing multiple site phosphorylation with opposing threshold 
control by Cdc55-mediated dephosphorylation. A switch-like inhibitory phosphorylation of Cdk1 by 
activated Wee1 is then induced by Cks proteins that interact with the Cdk1 active site and 
phosphorylated Cks consensus sites on Wee1. During the M phase, dephosphorylation of Cdk1 by 
phosphatase Cdc25 (a key regulator of mitotic entry) converts the kinase complexes into an active 
state, and leads to the progress of cell division. The activation of Cdk1 occurs in a stepwise manner 
controlled by a dynamic equilibrium between phosphorylation (de-activating) and de-
phosphorylation (activating) of Cdk1; phosphorylation of Cdk1 is regulated by the multiple-
phosphorylation state of Wee1. Intinitally during M phase, Cdk1 is held in a state of low activity for 
spindle assembly, while later the activity is switched to a state of high activity for spindle elongation 
at the time of highest expression of cyclin B (2011 Harvey). The activities of Wee1 and Cdc25 
appear to be oscillated in opposition to one another, similar to their balanced roles in Cdk1 
inhibition and activation (2005 Harvey).  
Beside the cell cycle control, a host protein SAMHD1, associated with restriction of 
HIV-1 replication in myeloid and quiescent CD4+ T cells, is regulated by Cdk phosphorylation (2013 
Cribier). SAMHD1 is one of the identified HIV-1 restriction factors, and consists of a sterile alpha 
motif (SAM) and a HD domain. It has been reported that SAMHD1 acts as a host restriction 
nuclease that can convert nucleotide triphosphates to a nucleoside and triphospate. In the presence 
of SAMHD1, HIV-1 infection appears to be blocked by reducing the level of dNTPs to a level too 
low to be available to a complete reverse transcription step. It has been observed that Cyclin 
A2/Cdk1 and Cyclin A/Cdk2 complexes phosphorylate SAMHD1 at its Thr 592 residue both in 
vitro and in vivo (2013 Cribier, 2014 St Gelais), whereas the phosphorylated SAMHD1 was 
significantly reduced in the PMA treated cells without affecting the level of unphosphorylated  
SAMHD1. A mutagenesis experiment showed that a Cdk phosphorylation-defective mutant 
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(T592A) has sufficient ability to inhibit HIV-1 replication in both of the PMA treated and untreated 
cell. In other words, the phosphorylation of SAMHD1 may play a role in a negative regulator of its 
restriction activity toward HIV-1. The authors proposed that the restriction activity of SAMHD1 
may be regulated by the equilibrium between Thr 592 phosphorylated and unphosphorylated forms 
favored in the proliferating cells (untreated cells), and non-proliferating cells (treated cells), 
respectively (2013 Cribier, 2014 St Gelais). 
1.3 Mass spectrometry 
Mass spectrometry is an analytical technique that determines mass-to-charge ratio (m/z) of 
ionized molecules. In MS analysis, analytes are ionized and volatilized in the source, separated by 
m/z in the analyzer, and counted in the detector. MS not only provides m/z of the molecules, but in 
some cases also disintegrate the molecular ions into particular fragmentation pattern for qualification 
and quantification through tandem mass spectrometry (MS/MS). Typically, a mass spectrometer 
consists of an inlet system, ion source, a mass-selective analyzer, an ion detector and data system 
(see Figure 1.1). There are a variety of combinations of the MS ion sources and analyzers designed 
for different analytical purposes.  
 
Figure 1.1 Schematic illustration of the MS instrument setup 
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1.3.1 Desorption Ionization 
 Mass spectrometers determine the mass-to-charge ratio (m/z) of gas-phase molecular ions 
generated in an ion source. Successful MS analyses are mainly dependent on the volatilization and 
ionization of analytes in a sample. In biological mass spectrometry, because the large polar 
biomolecules, such as proteins and polypeptides, are non-volatile, it has been challenging to desorb 
the macromolecules without decomposition into smaller charged particles until desorption 
ionization techniques was developed. Currently, the majority of biological MS is couple to one of the 
two desorption ionization techniques: Electrospray ionization (ESI) and matrix-assisted laser 
desorption ionization (MALDI). 
 ESI is an ionization process by which molecules was directly desolvated from solution-phase 
into gas-phase under atmospheric pressure. In the late 1980s, John Fenn, the 2002 Nobel Prize 
Laureate in Chemistry, applied ESI to convert liquid solution of large molecules into gas ions for 
MS. The ESI technique made a breakthrough for MS to be attributed to the applications of LC-MS 
in biochemistry. In ESI, the analytes are first dissolved in a solution of sufficient ionic strength, 
sprayed through an ESI needle with 2-5 kV voltages, positive or negative, that results in the 
accumulation of ions with identical charge polarity formed at the droplet surface at the tips of the 
capillary relative to vacuum orifice. To evaporate the neutral solvent molecules from the droplet 
surface, an inert gas flow is directed to the droplets to the spray exit where a “Taylor cone” shape is 
formed. As a result, the charge density increases while the droplet size decreases. When the coulomb 
repulsion between the like charges on the droplet surface exceeds the forces of surface tension 
(Rayleigh instability limit), the droplets break into smaller highly charged droplets. The same process 
occurs many times until only one charged analyte molecule is left in single droplet. The lone ions 
thus are ejected into the gas phase by electrostatic repulsion entering into the mass spectrometer to 
be analyzed (Figure 1.2). 
 10 
  
 
 
MALDI-MS is based on the concept of laser desorption mass spectrometry proposed in 
1976, in which pulsed laser has been employed to produce intact gas phase ions from solid samples 
(1976 Macfarlane). Figure 1.3 shows a scheme graph of MALDI. In the early investigation of laser 
desorption mass spectrometry, before the development of MALDI, only a few short peptides could 
be ionized and generate intact ions. Successful ionization was highly dependent on the specific 
physical properties of the peptides. In 1985, Hillenkamp and Karas first mentioned of the term 
“matrix-assisted laser desorption” in a publication, reporting the observations of intact protonated 
molecular ions of amino acids and dipeptides under different influence of UV- laser wavelength for 
desorption (1985 Karas). One of the experiments shows that the intact molecular ion of alanine was 
produced in the presence of tryptophan at an irradiation of about a tenth of that necessary for 
obtaining spectra of alanine alone. The authors proposed that the tryptophan acted as an “absorbing 
matrix” which absorbed excess of the laser energy and transfer appropriate energy to the non-
absorbing to generate a soft ionization, yielding intact molecular ions. In 1988, Hillenkamp and 
Figure 1.2 Schematic illustration of electrospray ionization. 
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Karas further performed experiments to successfully analyze bovine albumin (67 kDa) in the 
presence of high concentration of nicotinic acid, and observed the intact ions (1988 Karas). In 1988, 
Tanaka introduced another sample preparation method into MALDI-TOF-MS for detection of 
intact ions of large proteins, such as lysozyme (14 kDa) and chymotrypsinogen (26 kDa), by mixing 
an ultra fine cobalt powder with glycerol in an organic solvent and dropped a few microliters of the 
mixed solution onto a sample holder where sample solution is placed (1988 Tanaka). Both methods 
were a breakthrough in the application of MALDI-TOF-MS extended to include analysis of high-
mass molecules (proteins). Although today’s technique typically employs the use of a small organic 
acid similar to Hillenkamp and Karas’s method, Tanaka was awarded the Nobel Prize in chemistry in 
2002.  
+
Into mass analyzer
Matrix/analyte crystals+
+
+
+
+
+
+
+
+
+
+
+
+
Matrix ions
Analyte ions
Sample plate
Figure 1.3 Schematic illustration of matrix assisted laser desorption ionization. 
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1.3.2 Mass Analyzer 
 After being ionized to charged gas-phase particles ion an ionization source, sample ions are 
analyzed depended on their mass (m) and charge (z) in a mass-selective analyzer. In order to 
accurately separate and measure the m/z of the ions, the mass analyzer should be operated under 
high vacuum and calibrated by using ions of known m/z. There are five major types of mass 
analyzers: (i) Sector (magnetic or electric), (ii) Time-of-flight (TOF), (iii) Fourier Transform-Ion-
Cyclotron Resonance (FT-ICR), (iv) Quadrupole, (v) Ion trap. Different analyzers have different 
capabilities. In general, the analyzers are separated into two categories: high resolution (Sector, TOF 
and FT-ICR) and low resolution (Quadruple and ion-trap). High-resolution analyzers have better 
ability to distinguish between ions of high m/z, i. e. intact protein ions, than low-resolution 
analyzers, whereas, the speed of data processing of high-resolution analyzers can be limited. In 
recent years, hybrid analyzers are designed to include more-than-one analyzer with compensatory 
advantages of individual analyzers; it therefore causes the use of hybrid analyzers to rapidly become 
a popular technique to achieve high performance.  
 TOF analyzers separate ions of different m/z traveling with their mass-dependent velocities 
in space when the same voltage is applied. The TOF analyzers are commonly combined with 
MALDI ionization technique. After being ionized in the source, all ions gain the same amount of 
kinetic energy from an acceleration voltage. Therefore, the energy allows the ions to drift through a 
field-free flight tube under a vacuum with different velocities (K.E.=1/2 mv2 = zV; where KE, m, v, 
z are the kinetic energy, the mass of the ion, the velocity, the charge of the ion, and the applied 
voltage, respectively). In other words, for same distance, ions with larger m/z values fly more slowly, 
whereas ions with smaller m/z values fly faster to the detector; thus different drifting time can be 
recorded with respect to each m/z value. The TOF analyzers are advantageous of very high mass 
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range with high resolution and high sensitivity, although it requires high vacuum, and high 
voltage/pulsed/high precision electronics. 
 Sector or magnetic analyzers also separate ions in space according to their m/z values 
detected at different location. Most sector analyzers are of double focusing design, including an 
electrostatic analyzer and magnet sector. Ions formed in the ion source pass through the electrostatic 
analyzer, where the ions of different energy are trajected along different paths toward the magnet 
sector.  The magnet field is set up perpendicular to the path of the ions, leading to ions of identical 
m/z but different energy are brought to same focus at a single point on the detector. This 
combination of the electrostatic analyzer and magnet sector creates a high-resolution sector mass 
spectrometer with typical accuracy of 1-5 ppm (1997 Russell). The double focusing magnetic sector 
mass analyzers provide reproducibility with the best quantitative performance of all mass 
spectrometer analyzers, such as high resolution, high sensitivity, high dynamic range, but it is not 
well-suited for pulsed ionization methods (e.g. MALDI), and the instrument itself is usually bulky 
and higher cost than other mass analyzers. 
 FT-ICR analyzers measure m/z values of ions based on the cyclotron motion of ions 
caused by cyclotron frequency in a strong magnetic field. It is similar to a sector analyzer in that a 
magnetic field combined with electric field is used, but an ICR analyzer traps all ions inside of an ion 
trap (a cell) into an orbit by a centripetal force counterbalanced by a Forentz force (perpendicular to 
both the ions velocity and magnetic field lines) (2001 Schmid). In the cell, ions with the identical 
m/z have identical cyclotron frequency but differences in energies, orbital radii, and consequently 
velocities in their orbits. To obtain measurable signals, the ions are then excited by a pulse of a radio 
frequency, generating a larger cyclotron radius.  As the ions pass by the detection plates, an “image 
current” is induced. The complex signals are converted by Fourier Transformation (FT) from the 
time domain to the frequency domain, which can be further converted into a m/z spectrum. In 
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contrast to the magnetic sector analyzers, ICR is well suited for use with pulsed ionization methods 
(e.g. MALDI), has the highest recorded mass resolution of all mass spectrometer, and has powerful 
capability for MS/MS experiments. However, it suffers from a limited dynamic range and high cost 
of high vacuum and cryogenic cooling to lower signal to noise ratios. Besides, the accuracy is subject 
to space charge effects and ion molecule reactions, once ions are overfilled in the cell. 
 Quadrople analyzers are resonance mass filters that consist of four parallel rods in a square 
cylinder configuration. The ions are passed through the quadruple in a combination field of a direct 
current (DC) and a radio frequency (RF) voltage. Ions of each m/z value have their stable trajectory 
within a range of DC and RF values. In general, the DC and RF voltages are ramped together at a 
particular ratio, letting ions with a particular m/z value through the quadrupole to the detector at a 
time. The benefits of the quadruple analyzer include good reproducibility, relatively small and low-
cost systems, but it has limited resolution, and is not well suited for pulsed ionization methods.  
 Ion trap analyzers, analogous to the quadrupole, utilize ion path stability of ions for 
separating them by their m/z by adjusting a direct current voltage and radio frequency (RF) voltage. 
There are two configurations: three-dimensional quadrupole ion trap (3D-QIT), also called Paul 
traps) and a new generation two-dimensional linear ion trap (2D-LIT). Paul and Steinwedel invented 
the 3D-QIT in the early 1950’s after the development of electrodynamic quadrupole (1953 Pual). 
The 3D-QIT is a compact and inexpensive analyzer, which consist of a ring electrode with end caps 
on the top and bottom. The trap has high scan speed and high selectivity and sensitivity of tandem 
mass spectrometry (MSn). In the last decade, 2D-LIT was induced to increase the capacity and 
loading efficiency of the trap and reduce space-charge problems (changes in ion motion), resulting 
from too many ions in the trap that causes the mutual coulombic interaction of ions, and 
consequently induce mass shift and lower the resolution and accuracy observed. The details of the 
ion trap analyzers will be described in the following section. 
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 Orbitrap analyzer is a new type of high-resolution mass spectrometer, composed of an 
outer barrel-like electrode and a central spindle-like electrode along the axis (2008 Perry). As the 
name suggests, Orbitrap is considered an ion trap analyzer, but there is no RF or magnetic used to 
control ion stability. In Orbitrap, ions are trapped and oscillated into orbits between the two 
symmetric electrodes, where a DC voltage applied results in the electrostatic potential distribution-a 
combination of quadrupole and logarithmic potentials. The axial oscillation frequencies, which are 
exclusively dependent on m/z but not on initial velocities as well as coordinates of ions, can be 
detected by measuring the image current on the outer electrodes. The time-domain frequency signals 
are further converted into m/z values shown on a spectrum. Similar to FT-ICR, advantages of the 
Orbitrap include high resolving power (up to 150,000), multi-fragmentation capability and high 
sensitivity in the attomole to femtomole range for measurements of intact proteins, whereas 
Orbitrap may outperform FT-ICR because of increased space charge capacity at higher masses, 
larger trapping volume, and, most importantly, a cryogen-free detection system (2005 Hu, 2006 
Macek). 
 Hybrid mass spectrometers combine more than one type of mass analyzer that each has 
their own pros and cons. The hybrid capability allows for the combination of the different desirable 
performance characteristics offered by various types of analyzers into one mass spectrometer (2008 
Glish). Most importantly, the hybrid analyzer provides a platform to perform MS/MS experiments 
with high resolving power, accuracy and analysis speed; e. g., ions are mass-selected in the first 
analyzer, reacted and the product ions are then analyzed in the second analyzer. Although perhaps 
more than 30 configurations of hybrids have been explored, only a few have been commercialized 
and remain popular, such as Q-TOF, Ion trap-TOF, and LIT-Orbitrap (2012 Paulo). In early years, 
most research was devoted to MS/MS sector instrumentation. However, in 1978, Yost and Enke 
first published MS/MS results in a triple quadrupole system – a key development in hybrid MS/MS 
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mass spectrometry. The next year, upon the comparison of different performance characteristics of 
various analyzers, it was observed that the MS/MS collision in QqQ hybrid instruments required 
lower energy but was more efficient than the collision used in Sector instruments (2008 Glish). 
Later, in the 1980’s, Glish and Goeringer at Oak Ridge National Laboratory combined a quadrupole 
mass filter with a TOF analyzer (Q-TOF) (1984 Glish), which has later become one of the most 
popular mass spectrometers currently used due to the main advanced design of Orthogonal 
Acceleration that is placed between the quadrupole and TOF analyzer for minimizing the effect of 
different ion entrance velocities, leading to a high resolution. As the quadrupole is operated in RF-
only mode, all ions are passed from the ion source as an ion beam to the orthogonal acceleration 
region, where a acceleration pulse is applied orthogonal to the direction of the entering ions to send 
the ions down the flight tube. This Q-TOF hybrid design exploits the higher MS/MS efficiency, 
which was demonstrated for QqQ in early years, and the high performance in sensitivity, resolution, 
and accuracy of a TOF analyzer. Subsequently, TOF was coupled to ion trap analyzers, very similar 
to Q-TOF, to offer high MSn capability and high resolving power and mass accuracy at the same 
time.  The most recent type of commercialized hybrid instrument is LIT-Orbitrap with an ion 
collector “C-trap” between the two analyzers. Instead of a continuous stream, the ions are 
accumulated in LIT while another packet of ions is collected by the C-trap and ejected into Orbitrap 
(2008 Perry).  
1.3.3  MS techniques applied to this thesis – MALDI-LIT MS 
 Most of the research presented in the thesis is carried out by MALDI-linear ion trap (LIT) 
MS. In early years, the MALDI technique was typically combined with TOF because of the pulsed 
nature of MALDI that easily interfaces with pulsed TOF measurements, especially with 
implementation of delayed-ion extraction (1995 Brown; 1995 Vestal) and, which allow for the better 
reproducibility, accuracy, and resolution. Nowadays, MALDI is coupled to nearly every MS analyzer 
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available for various experiments, utilizing its high tolerance for contaminants, simple sample 
preparation, high sensitivity and wide analytical mass range. Although abundance of sample 
preparation methods and a wide range of matrices have been proposed and applied to MALDI 
analysis, the detailed mechanism is not totally understood and still being investigated. It is generally 
accepted that MALDI is a soft ionization with a combination of desorption and ionization (2006 
Knochenmuss) divided into two steps. The first step is to form gas-phase primary ions, i.e. 
protonated matrix ([M+H+]); the second step is to involve proton transfer from the primary ions to 
an analyte (A) through gas phase ion-molecule reaction to produce protonated analyte secondary 
ions, i.e. [M+H]+ + A  M + [A+H]+. 
 MALDI is an extremely complex ionization, involving many desorption/ionization events 
that occur in a micro to nanosecond during or shortly after laser ablation. Over the last decade, 
scientists have proposed differing hypotheses that attempt to explain the complicated ionization 
mechanism in a somehow unpredictable manner. The mechanism for the formation of ion-molecule 
secondary ions is less controversial than the formation of primary ions. The mechanism for the 
formation of primary ions proposed in the literature mainly encompasses two models, the gas-phase 
proton transfer model (2006 Knochenmuss; 1987 Karas) and the cluster (lucky survivor) model 
(2000 Karas; 2006 Alves; 2002 Fournier).  
In the gas-phase proton transfer model, desorption is initiated by photoionization, where 
matrix absorbs photon energy from laser ablation and transfers it into excitation energy causing the 
formation of matrix primary ions. However, the mechanism is insufficient to explain how the high-
mass protein molecules can be desorbed from the matrix and suspended into the gas phase. In the 
cluster model, similar to the mechanism of ESI proposed by John Fenn, upon the laser ablation, the 
gas-phase charged clusters may be produced by ion evaporation mechanism described by Iribarne 
and Thompson (1967 Iribarne). The most notable assumption in the cluster model is that all the 
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ions may exist in the sample before laser ablation; during ablation, the desorbed cluster ions are re-
neutralized in gas phase, but only a few “lucky survivor” ions can survive as singly charged ions 
detected. Yet, a problem is why the formation of low charged ions is much more favorable than that 
of highly charged ions during desorption if proteins can carry several charges, which was commonly 
observed in ESI (Figure 1.4) (2012 Trimpin).  Recently, both models were discussed by Jaskolla and 
Karas, reporting that both of the gas-phase proton transfer pathway and the lucky survivor pathway 
are true under multiple investigations, and both pathways may be part of one  overall MALDI 
mechanism (2011 Jaskolla), but the details still remain problematic.  
The typical MALDI sample preparation involves dissolving a small organic acid (mostly 
aromatic compounds used for efficient energy absorption during laser ablation) at a high 
concentration in an organic solution, mixing sample solution with excess matrix, spotting the 
mixture of sample and matrix on a MALDI plate, and allowing the sample to co-crystalize with the 
matrix prior to analysis. Several important factors determining a successful MALDI analysis in 
sample preparation steps are choice of matrix and matrix solvent, the ratio of matrix to sample, 
concentrations of samples, consideration of analyte nature (i.e. the compatible solubility of matrix 
and analyte), homogeneity of spots, and possible contamination that affects signal-to-noise ratios on 
spectra. A wide variety of matrices have been used in MALDI dependent on specific analytes.  Three 
common matrices for peptides and proteins are α-cyano-4-hydroxycinnamic acid (CHCA), 2,5-
dihydroxybenzoic acid (DHB), and sinapinic acid (SA) (Figure 1.5).  
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Figure 1.4 Electrospray Ionization (ESI) and Matrix Assisted Laser Desorption Ionziation 
(MALDI). (A/B) an ESI/MALDI mass spectrum of a protein. (C) charge states and 
corresponding mass-to-charge ratios (m/z) of the protein. 
 
Figure 1.5. Typically used matrices in MALDI-MS. 
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Linear Ion Trap analyzer (LIT) 
 Before the development of LIT, the ion-trap analyzers were designed as a 3D-cylindrical 
symmetry mass analyzer (3D-QIT), roughly the size of a tennis ball, made up of a central ring 
electrode and two end caps on the top and bottom (1990 Paul; 1991 Cooks; 1997 Jonscher) (Figure 
1.6). In the 3D trap, ions of a particular range of m/z can be trapped in an oscillating electric field 
around the inner electrode with the damping gas (helium) by applying a RF oscillating potential to 
the ring electrode (the end cap electrodes are held at an offset DC potential to prevent ions from 
escaping axially) for a certain time interval. The presence of the helium gas in the trap is to stabilize 
the ion trajectories and, if MS2 is employed, to collide with the molecule ions. After that, the ratio 
frequency amplitude is ramped (an additional auxiliary radio frequency voltage, 1/3 frequency of the 
main voltage, is applied) over a period of time to destabilize the ion trajectories and then eject the 
ions toward the detector.  
 
Figure 1.6 Three-dimentional ion trap configuration with central ring electrode 
and two end-cap electrodes. 
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 2D-LIT analyzers have evolved recently (2002 Schwartz; 2002 Hager) (Figure 1.7). The 
physical appearances of the LITs are more closely related to those of quadrupoles, but the LITs are 
still designed based on the principle of the QITs. As shown in Figure 1.7., the quadrupole was cut 
into three axial sections, including the front section, the end section, and the x rod of the central 
section. The three sections are connected a discrete DC potential and two different phases of RF are 
applied to each pair of two opposite electrodes, allowing the ion trajectories take the shape of 
sausage along the z-axis rather than at a single center point of 3D-QIT. This results in greatly 
increase the trap’s capacity and decrease the space charge effects. Another advantage of LIT is that 
ions will not be ejected from the front and the end section, but from the x rod of the central section 
to the two detectors placed axially on either side of the rods. Thus, a large amount of ions entering 
axially can be detected to reach maximum sensitivity. The LIT analyzer has been shown to 
successfully overcome two fundamental limitations of the traditional 3D-QITs, ion capacity and trap 
efficiency. The further combination of LTQ with other high resolution analyzers, such as LIT-TOF 
(qTOF) and LIT-Orbitrap, has provided powerful tools for biomolecule analysis.  
 
Figure 1.7 Two-dimentional linear ion 
trap configuration with the quadrupole 
rods cut into three axial sections. 
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1.3.4    Tandem Mass Spectrometry (MS/MS) 
 MS/MS is a technique where ion fragmentation occurs in a collision chamber before the 
mass spectrum is acquired.  The fragment information is useful for peptide/protein sequencing, 
structural elucidation, analyte identification and quantification through fragment fingerprinting. 
Several approaches to MS/MS experiments (product ion scan, precursor ion scan and neutral-loss 
scan) can be conceived in two ways: in time or in space with collision induced dissociation (CID), the 
most commonly used method of fragmentation, also called collisionally activated decomposition 
(CAD) (2002 McClellan). Tandem-in-space MS/MS generally is performed on magnetic sectors and 
quadruple based mass spectrometers. The processes occur sequentially in separate regions of the 
instruments. In the first region, which is most often a quadruple filter, specific ions (precursor ions) 
are induced into the subsequent part of the instrument, a gas-filled collision chamber, for 
fragmentation. All fragment ions (product ions) further enter into the third section of the instrument 
to be scanned (see Figure 1.8). Tandem-in-time MS/MS can be performed by an ion trap mass 
spectrometer with, for example, product ion scan which acquires a mass spectrum of products ions 
produced by retaining a precursor ion in the trap chamber for a period of time for and colliding the 
ion with a damping gas, such as helium.  
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Figure 1.8 Schematic illustration of tandem mass spectrometry. 
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 MS/MS experiments can be classified into three types (precursor ion scans, neutral loss 
scans, and product ion scans), according to which these species are monitored. During MS/MS, 
specific ions (precursor ions) are selected based on m/z values and collided with a collision gas into 
fragments (product ions). Precursor ion scanning is to detect a range of m/z of precursor ions as a 
particular m/z of the product ions is fixed. Neutral loss scanning is to synchronously scan both 
precursor and product ions, but offset by a constant m/z value corresponding to a specific neutral 
loss fragment. Product ion scanning is to scan product ions (fragments) derived from an isolated 
precursor ion of only a selected m/z. Because analyte ions have been isolated from the background 
ions for detection, MS/MS, is able to strongly reduce the background, leading to a lower detection 
limit achieved and higher signal-to-noise ratios shown in MS/MS spectra, in most cases. Moreover, 
tandem-in time MS analyzers (traps) have capability of performing multi-fragmentation (MSn), in 
which specific ions can be selected for further fragmentation sequentially from the previous MS/MS 
step. The controllable MSn experiments are usually applied to structure elucidation due to its power 
to continually break down any interested analyte fragments into smaller pieces to gain a better 
understanding of the structure or sequence of a peptide. Thus, tandem MS (MS/MS or MSn) has 
been widely applied to qualitative and quantitative proteomic analysis with the advantages of high 
sensitivity and selectivity, providing abundant tandem mass spectra with specific fragmentation 
information needed for structural identification (1990 Johnson).   
 A peptide sequence is composed of three types of bonds that can be fragmented along the 
amino acid backbone: CH-CO, CO-NH, and NH-CH. A nomenclature for peptide sequencing by 
MS/MS was originally proposed by Roepstorff et al., and later modified by Biemann (1984, 
Roepstorff; 1988, Biemann). Figure 1.9 illustrates six possible fragment ions for each amino acid 
residues, caused by the three potential cleavage sites along the sequence backbone.  The a, b, and c 
ions are formed due to charge retention on the N-terminal fragment, whereas the x, y, z ions 
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originated from the charge retention on the C-terminal fragment. Upon CID fragmentation, the 
cleavage occurs at the CO-NH bonds, resulting in dominant b and y ions shown on MS/MS spectra. 
The fragment ions are structurally useful for determining a peptide sequence. 
 
    
 
 
 
1.4     Protein identification and phosphorylation analysis in MS 
1.4.1    MS protein identification approaches  
 Two fundamental MS protein identification approaches are termed “top-down” and 
“bottom-up”. In top-down protein analysis, intact proteins are introduced into MS without 
proteolytic digestion and are fragmented into smaller peptide cations or neutral fragments. In 
bottom-up proteomics, purified proteins are treated with a protease to perform proteolytic digestion 
before being subjected to fragmentation for MS analysis.  
x1
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Figure 1.9 Peptide sequence fragmentation 
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 Bottom-up proteomics measures exact mass of peptides from digests derived from proteins 
to identify the corresponding proteins; and determining fragments of the digest peptides to know 
structural information. The conventional bottom up approaches can be gel-based or gel free. 
Proteins are first extracted from a sample of cells, and the protein mixture is separated by one or 
two-dimensional gel or online liquid chromatography (2014 Magdeldin). The two-dimensional gel 
separates proteins by their isoelectric point and then by its masses using a standard one-dimensional 
gel. Once the proteins are isolated from one another, the individual protein bands of interest are cut 
out and digested enzymatically with a suitable enzyme (typically with trypsin) or chemically with a 
strong acid (such as 12% formic acid) into small peptides (digests) which are then extracted prior to 
MS analysis. Because the peptides have the better solubility and ionization efficiency, it is possible to 
readily detect the peptides by MS, compared to the parent proteins (2006 Chait). The mass spectra 
(peptide mass fingerprinting) from its proteolytic digestion are assigned to proteins by comparison 
with a sequence database. In addition, with the use of MS/MS, partial amino acid sequences of 
individual peptides can be obtained to further characterize and confirm the sequence.  
 With top-down analysis, the proteins remain intact without any digestion before being 
introduced into MS (2011 Zhang). To determine modifications in the protein sequence, the exact 
mass measurement of the intact protein is compared to with calculated values based on the DNA-
predicted protein sequence; then, the target protein is isolated and fragmented in gas phase by 
tandem MS for sequence mapping.  However, the top-down approach still suffers from several 
limitations currently. Because high-mass proteins yield complex isotopic distribution patterns shown 
on the mass spectra, the top-down MS requires a costly high-resolution mass analyzer at high-mass 
range, such as Orbitrap or FT-ICR, to avoid any overlapping of the distributions. In addition to the 
complex isotopic distribution, multiply charged proteins generated in ESI after chromatographic 
separation also results in complex spectra. For intact protein tandem MS, poor dissociation 
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efficiency (low sequence coverage) has been observed for very large proteins when many common 
dissociation processes such as CID are used, and the mechanism of gas phase protein fragmentation 
is not fully understood, even though many researchers have turned their attention to develop new 
fragmentation methods and the instrumentation (one such method is electron-transfer dissociation 
(ETD) that generates c- and z-type fragment ions and preserves unstable side-chain modification 
during MS/MS). Moreover, the ionization efficiency for very large proteins is limited, leading to 
difficulty of trace analysis of the large protein. For these reasons, most of the protein MS 
identification and quantification still relies on bottom-up approaches.  
 
1.4.2 Phosphorylation analysis in MS 
 Phosphorylation occurs at least 30% of proteins in human (2007 Ubersax). A new phosphate 
group induces a conformational change of target proteins that can be activated, deactivated, or 
changed in function. Numerous cellular functions are regulated by protein phosphorylation, a 
reversible and selective reaction controlled by kinases and phosphatases. The kinases and 
phosphatases have been found to be involved in a large number of human diseases, resulting from 
their mutation, over expression or malfunction (2001 blume-Jensen). Phosphoproteomics with 
recent advances in mass spectrometry (MS) has become an important approach to understand the 
entire phosphorylation network, for example, which protein are phosphorylated; which sites are 
phosphorylated on the proteins; what is the stoichiometry of these phospho-sites; which kinase 
phosphorylates the site; what is the biochemical function of the phospho-event; what is the cell 
biological function of the phosphor-event. 
 Traditionally, to trace phosphorylation, radioactive 32P is introduced into cellular proteins via 
the transfer of α-phosphate of labeled ATP by kinases (1986 Garton). Another method is to utilize 
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antibodies against phosphorylated proteins by western blotting (1999 Dimmeler). The probing 
methods are sensitive and highly selective; however, they provide no information of specific 
phosphorylation sites, unless specific antibodies are produced against each phosphorylation site on a 
protein, and phosphorylation on differing sites has to be determined individually, which can be 
prohibitively expensive. MS is a powerful tool for probe-free phosphorylation analysis in which the 
attached phosphate group can be observed on mass spectra with a mass shift of +80 Da. The 
specific mass difference between modified and unmodified proteins suggests the presence of protein 
modifications (2004 Chang). A number of MS strategies have been developed to perform 
phosphorylation quantification, yet the technique is being explored to find better and more efficient 
quantification approaches.  
In phosphoproteomic analysis, the phosphorylated proteins firs t are isolated from tissues or 
cells, digested into peptides subjected to bottom-up analysis, or directly subjected to top-down 
analysis by mass spectrometry for site-specific identification and quantification. However, the 
dynamics and heterogeneity of protein phosphorylation increase complexity of the 
phosphoproteomic analysis, leading to the challenge of deciphering phosphorylation cellular 
signaling network. For instance, the same residue may be phosphorylated by several kinases through 
a variety of mechanisms at different time. Furthermore, the phosphorylation level of a substrate 
fluctuates dynamically in the cellular network, i.e., some proteins containing phosphorylated residues 
may be found to be strongly phosphorylated, weakly phosphorylated or un-phosphorylated as 
functional proteins in cells (2013 Tyanova). To construct the detailed phosphorylation signal 
pathways, it is therefore important to develop methodologies for identification and quantification of 
the dynamic and heterogeneous phosphorylation. 
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1.4.3    MS-based quantitative analysis 
  Measurement of phosphorylation stoichiometry is biologically important for understanding 
the functional dynamics of phosphorylation regulation in a cell. To do this, MS has been regarded as 
a powerful tool not only for protein identification but also protein quantification. MS-based 
phosphorylation quantification can be classified into two major strategies: absolute quantification, 
which determines the exact amount of proteins in the sample a quantified standard; and relative 
quantification, which evaluates phosphorylation changes with experiments. Unfortunately, MS is not 
inherently quantitative (2009 Doerr), because ionization efficiency of many peptides is different in a 
given sample and the instrument responses are unpredictable. Many quantitative MS approaches 
have also been developed to overcome this limitation. For instance, protein or peptide samples can 
be isotopically labeled and the abundance of the labeled target can be relatively or absolutely 
compared to the abundance of the nonlabeled or differently labeled target. Another quantitative 
approach similar to the labeling method is called isotope dilution, which is used by spiking 13C-or 
15N-stable isotope analogs of peptide analytes in defined amount as internal standard before MS 
analysis. Besides, due to a strong demand for a lost cost and rapid analysis, MS label-free approach 
has been recently proposed to quantify protein or peptide amounts in different samples in response 
to the changes in signal intensities.  
 
Isotope labeling methods 
 MS-based relative quantitative proteomics can be achieved with comparison of two or more 
samples by using stable isotope labeling methods. Some of the recently developed labeling methods 
are: Stable Isotope Labeling by Amino acids in Cell Culture (SILAC) (1999 Oda), Isobaric Tag for 
Relative and Absolute Quantitation (iTRAQ) (2004 Ross), Stable Isotope Dimethyl labeling methods 
(2009 Boersema). The SILAC method relies on the metabolic incorporation of a “heavy” or “light” 
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form of a given protein or peptide with substituted13C6-Lys and 
13C6, and 
15N4-Arg residues. In 
SILAC experiments, cells are grown in cell media where the control cell medium contains the natural 
(light) proteins; whereas, the reaction medium (i.e. kinases treated) is prepared where the light amino 
acids are replaced by heavy SILAC amino acids. The two cell populations are then mixed prior to 
MS analysis, where a difference in MS signals between light and heavy masses of peptides represents 
the quantitative difference in the target proteins between control and reaction medium. The ratio of 
the light-to-heavy mass response is utilized for the relative proteomic quantification (i.e. 
phosphorylation quantification).  
 The iTRAQ method uses tandem mass spectrometry (MS/MS) and isobaric labeling on the 
primary amines of peptides and proteins. The iTRAQ reagents are four isobaric tags, which have an 
identical total mass of 145 Da, consisting of three elements: a peptide reactive group (NHS ester) for 
N-terminal labeling of peptides, a balance group (28- 31 Da) and a reporter group of variable mass 
(m/z 114-117) with difference in the stable isotope composition of the reporter groups and the 
balance groups, such as 
13
C, 
18
O and 
15
N (Figure 1.10) (2004 Ross). The reagents tag samples 
individually by replacing the peptide reactive group with primary amines of peptides and proteins 
prior to MS/MS analysis, where the reporter group falls off from each tagged compounds, 
producing different reporter fragment ions shown on the same mass spectrum for quantification. 
The pattern of the reporter fragments shown as differing masses allows multiplexing four different 
samples, and all samples could be identified and quantified in one tandem mass spectrometric run to 
achieve a high throughput analysis (Figure 1.11).  
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Figure 1.10 The structure of iTRAQ reagent composed of a reporter 
group, balance group and reactive group. 
Figure 1.11 MALDI-MS workflow with iTRAQ labeling (m/z  114 – 117) 
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In dimethyl labeling experiments, protein samples are first treated with protease, and free 
amines on the derived peptides of different samples are labeled with normal or deuterated 
formaldehyde. The labeled samples are then mixed and analyzed by LC-MS whereby the change in 
mass of dimethyl labels is used to compare the peptide abundance in different samples. Demethyl 
labeling is based on dimethylation of primary amines (the N terminus and the side chain of Lysine 
residues) in a peptide mixtures with formaldehyde to convert the primary amines to dimethylamines. 
It is observed that the differential peak mass by 28 Da for each derivatized sites and by 4 Da for 
each isotopic dimethyl labels (Figure 1.12) (2009 Boersema). This method is rapid and economic to 
globally detect and quantify phosphorylation by comparing the signal response with a mass shift by 
labeling.  
 
 
  
Isotope dilution methods 
 While isotope labeling methods mostly provide relative quantification, MS-based absolute 
quantification is also possible for determining absolute abundance of phosphopeptides. Isotope 
dilution has long been for small molecule quantification by the addition of defined quantities of 
isotope standards as ideal internal standards, which have the chemical behaviors identical to the 
Figure 1.12 Labeling reactions of dimethyl labeling. 
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analytes. In the past decade, this approach has been transferred to absolute quantification of 
proteins and peptides in biological samples. In 2003, Gygi et al. presented an absolute quantification 
(AQUA) strategy in quantitative proteomics where proteins are proteolyzed with trypsin in the 
presence of the synthesized isotope standards (AQUA peptides), followed by extraction, 
chromatographic separation, and analysis using selected reaction monitoring (SRM) on triple 
quadrupole mass spectrometers (2003 Gygi). The absolute phosphorylation quantification of a 
tryptic peptide containing a specific phosphorylation site can be achieved by utilizing the ratios of 
native and corresponding AQUA peptide chromatographic peak areas. A similar strategy was 
described by Ciccimaro et al. to absolutely quantify phosphorylation of kinase activation loop of 
cellular focal adhesion kinase (FAK) with addition of a labeled phosphorylated FAK standard and a 
labeled control peptide along with the edogenous FAK before cell lysis and protein digestion, 
respectively (2009 Ciccimaro). It is possible to calculate amount of phosphorylation of the 
edogenous FAK by comparing the observed amount of the edogenous FAK to the amount of the 
control peptide with corrections for immunoprecipitation efficiency during protein isolation from 
cell lysate. Overall, this labeling dilution approach is, however, not used for a large scale analysis and 
limited to the individual analyte, because of the difficulty of obtaining these internal standards, 
especially when a large number of proteins have to be quantified.  
Label-free methods 
 There has been growing interest in the use of label-free approaches to quantitative mass 
spectrometry. Label-free phosphoproteomics allows samples to be directly and separately analyzed 
by MS without merging (mixing of unlabeled and labeled samples), resulting in a higher coverage of 
a dynamic range. It also has been reported that the measurements are linearly proportional to the 
concentrations of interest peptides in the range of 10 fmol to 100 pmol (2012 Nilsson). Most 
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importantly, a large amount of samples can be analyzed at the same time without the limit of the 
number of labeling reagents.  
 There are two ways of determining the abundance of a peptide or protein in label-free 
quantitative phosphoproteomics: (1) based on intensity changes in peptide peaks, (2) the spectral 
counting of analytes after LC-MS/MS analysis. The former methods are conducted by comparing 
ratios of intensities of phosphorylated to nonphosphorylated peptide ions. For example, Steen et al. 
developed a label-free phosphorylation quantification method by using the measurements of 
normalized ion intensities of phosphopeptide relative to nonphospho-tryptic peptides from the 
target protein (2005 Steen). This method was further modified by Yi et al. to normalize the peak-
area of the reconstructed ion chromatogram for the target phosphopeptide against the peak areas of 
other nonphospho-tryptic peptides as endogenous internal standards (2007 Yi). The normalized 
peak areas for untreated and treated samples were compared for relative quantification of 
phosphopeptides. However, this method may be problematic for quantification of peptides 
containing adjacent phosphorylation sites regulated more than one kinases.  
 The same research group, therefore, reported the latter method by monitoring MS/MS 
product ions instead of parent ions for label-free phosphorylation quantification. The samples were 
first tryptically digested, chromatographically separated, and then analyzed in MS. The intensities of 
the MS/MS or even MSn fragments, in which b and y ions are unique to each phosphorylation 
isoform, were applied to detect phosphorylated tryptic peptides in a linear and reproducible manner 
(2010 Langlais). In general, the major limitation of label-free quantification is the requirement of 
extra care of intersample preparation and purification for reducing matrix effect prior mass 
spectrometric analysis; that explains why chromatographic separation coupled to ESI-MS has been 
considered to be the most desirable platform for the label-free analysis in spite of the complexity of 
its and time-consuming compared to MALDI-MS.  
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2.1  Introduction 
Phosphorylation is one of the most important post-translational modifications. Many 
proteins have been known to be phosphorylated at numerous sites by kinases, resulting in a change 
in function. To understand the special characteristics of phosphorylation requires analytical methods 
to quantify either single or multiple phosphorylation sites within a substrate. Many methodologies 
have been used to identify and quantify phosphorylation, such as western blotting, radioactive 
phosphate labeling, flow cytometry, and mass spectrometry (1999 Kreegipuu, 2002 Zhang, 2008 Ma). 
Mass spectrometry (MS) has become an irreplaceable technique in phosphorylation analysis, in 
which a signal corresponding to the phosphate moiety can be detected on the mass spectrum, 
because it has the capability to readily determine site-specificity, and does not require the generation 
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of sequence-specific antibodies. The general workflow for MS based quantitative proteomic analysis 
relies heavily on HPLC-ESI-MS technique in the combination with either labeling or labeling-free 
method (shown in Figure 2.1A). Calibration curve construction generally is required, especially 
when label-free methods are applied. Both the labeling and label-free methods for absolute and 
relative quantification have pros and cons, as mentioned above in chapter 1. For instance, the 
labeling methods are limited to high cost and less flexibility, but are generally considered more 
reliable. Recently, label-free methods have attracted growing attention due to their simplicity, 
reduced sample preparation and high analytical dynamic range; however the procedures of sample 
preparation and chromatographic separation are a requisite for ESI-MS or ESI-MSn in the workflow 
to reduce its spectral complexity and ion suppression effect. To overcome this conflict, MALDI has 
great potential to replace the current ESI strategy to build up a simpler workflow for proteomic 
analysis (Figure 2.1B).  
ESI and MALDI are the most common ionization techniques generally used in protein mass 
spectrometry (2011 Kuklenyik). ESI can produce multiple charged ions that could be problematic 
while analyzing protein or peptide mass spectra due to the spectral complexity. Thus, for most 
phosphoproteomic analyses, ESI-MS must be coupled to liquid chromatography to simplify the 
complex spectra (2011 Zhang). Compared to ESI, MALDI has more tolerance to buffer or 
impurities in the sample, so it requires only simple sample preparation, is generally fast and easy to 
use, and yields simpler spectra (singly charged peptide ions) that ordinarily do not require 
chromatographic separation. In spite of this, MALDI is inherently less quantitative due to 
unpredictable difference in ionization efficiency and in absolute ion intensity arising from 
heterogeneities in analyte/matrix crystallization. 
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 Figure 2.1 General workflow for proteomic quantification. (A) Current workflow with 
ESI. (B) A simpler workflow proposed with MALDI in the study.    
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To minimize the quantitative problems, isotope derivative methods are generally required in 
quantitative proteomic MALDI by taking advantage of the fact that isotopomers respond identically 
under MS conditions, but are able to be separated by mass. It has been recently demonstrated that 
MALDI combined with isotope labeling methods is feasible to protein quantification in proteomic 
analysis (2009 Johnson). While effective, such isotopic labeling methods are limited in their 
multiplexing capacity, high cost, requirement for specialized reagents and a narrow dynamic range 
(2012 Gunasekera, 2010 Gouw, 2010 Boersema, 2009 Ye). In addition, the inherent limitations in 
reproducibility of MALDI-MS can at least in part be overcome by increasing the signal acquisition 
time. The signal from a single spot can be interrogated for several minutes to average the signal from 
thousands of laser shots, as compared to the smaller number of scans generally available when 
limited by a chromatographic time scale in ESI-LC-MS.  
Label-free strategies have been increasingly prominent as alternatives for quantitative 
proteomics due to their lower cost and convenience. Liquid chromatography MS (LC-MS) has been 
one of the fundamental techniques in the label-free relative-quantitative proteomics (2007 Levin, 
2008 Asara). Chromatographic retention peaks can be integrated with external calibration to 
measure peptide abundance (2010 Zhu). However, the chromatographic task is time-consuming and 
may suffer from interference problems. Mobile phase conditions must also be carefully controlled to 
avoid changing the solubility and ionization of the peptide analytes. As an alternative to 
chromatography based label-free methods, label-free MALDI-MS methods are in rising demand for 
high-throughput proteomic analysis. Kinumi et al. has successfully measured phosphopeptides 
derived from the phosrestin protein by using a label-free MALDI approach with calibration 
construction by plotting signal ratios versus peptide amount ratios, quantifying the ratio of 
phosphopeptide to total peptide (2005 Kinumi). The calibration curve showed a linear correlation 
between the peak ratios and amount ratios.  In other cases, the unphosphorylated and 
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phosphorylated substrates have different ionization efficiencies, resulting from their differing 
physicochemical properties. For example, a study by Parker, et al. demonstrated non-linear 
relationships between signal ratios and amount ratios for seven different peptides using MALDI 
ionization (2008 Parker). This may be due to differential ionization effects between the different 
peptides. Therefore, in this chapter, to solve the problems, we aim to develop MALDI label-free 
mass spectrometric strategies as alternatives for quantitative single or double-site 
phosphoproteomics with the advantage of lower cost, simplicity and convenience.  
2.2 Label-free MALDI-MS for single phosphorylation quantification 
In this study, we present a new MALDI-MS method for quantification of 
phosphorylation stoichiometry, termed Double Reciprocal Isotope-free Phosphopeptide 
Quantification (DRIP-Q). This method does not require isotope labeling, chromatography, or 
construction of calibration curves. Instead, a double reciprocal transformation is applied that 
accounts for differences in ionization efficiencies of analytes, allowing for the direct comparison of 
unphospho- and phosphopeptide signals. The method is shown to be robust and reproducible over 
a wide range of analyte concentrations using three different peptide models encompassing 
phosphoserine, phosphothreonine and phosphotyrosine. The results obtained with this method are 
comparable to those obtained using traditional stable isotope labeling. To our knowledge, this is the 
first report of a calibration-curve-free MALDI-MS method for the determination of 
phosphorylation. 
2.2.1 Materials and methods 
Materials 
HPLC grade water, acetonitrile, and formic acid were purchased as HPLC grade from Fisher 
Scientific (Pittsburg, PA, USA). Synthetic peptides, AAAAYRAAR, LRWGFTTPDKKHQKEPPF, 
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and RQSVELHSPQSLPR, were used for the quantitative method development. The peptide, 
AAAAYRAAR, and its phosphorylated form, AAAApYRAA, and their [13C3]-alanine labeled forms, 
were synthesized and purified by University of Utah DNA/peptide facility. The HIV-RT peptides, 
LRWGFTTPDKKHQKEPPF, containing a Cdk phosphorylation consensus sequence 
(S/T)PXR/K, and its phosphorylated form, LRWGFTpTPDKKHQKEPPF,  were synthesized in 
house using standard fmoc-based solid-phase peptide chemistry. The AQP2-peptide, 
RQSVELHSPQSLPR, and its two phosphorylated forms at pSer-256 and pSer-261, 
RQpSVELHSPQSLPR, and RQSVELHpSPQSLPR, were purchased from Anaspec (Fremont, CA). 
MALDI-MS quantitative analysis 
Peptide standards, AAAAYRAAR (peptide 1), LRWGFTTPDKKHQKEPPF (peptide 2), 
and RQSVELHSPQSLPR (peptide 3), and their phosphopeptides were selected as three different 
model systems to establish the label-free MALDI-MS quantitative method. 1 μL of the sample 
mixture of the unphospho- and phosphopeptide standards with various phosphorylation fractions 
was mixed with 9 μL of matrix solution. Then, 1 μL of the peptide mixture with the matrix was 
spotted on a MALDI plate prior to MALDI-MS analysis. MALDI-MS experiments were carried out 
on a Thermo LTQ XL linear ion trap mass spectrometer (Thermo Scientific) was equipped with a 
MALDI ion source. α-Cyano-4-hydroxycinnamic acid (CHCA) was purchased Sigma-Aldrich (St. 
Louis, MO, USA) from 2,5-Dihydroxybenzoic acid (DHB) was purchased from Acros Organics 
(Morris Plains, NJ, USA) and used without further purification. A saturated aqueous solution of a-
Cyano-4-hydroxycinnamic acid (CHCA) (Sigma-Aldrich, St. Louis, MO, USA) in 0.1 % 
trifluoroacetic acid/acentonitrol (30/70, v/v) or 2,5-Dihydroxybenzoic acid (DHB) (Acros Organics 
Morris Plains, NJ, USA)  mixed with water / acetonitrile (50/50, v/v) in a 1:4 ratio (v/v) was used 
as a matrix solution. Full scan mass spectra were acquired in positive mode by 400 scans with 
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automated gain control (AGC) set at 300,000 counts with automated spectrum filter (ASF) off, 3 
microscan/step, and processed  by XcaliburTM 2.0.7 software. 
In vitro Phosphatase assay 
The phosphopeptide (AAAApYRAAR) was applied to the phosphatase assay, which was 
performed in a final volume of 50 μL, containing 25mM of Ammonium bicarbonate buffer, 4 Units 
of Alkaline Phosphatase (Roche), and 1.56 nmole of the phosphopeptide substrate at 30 °C for 1 h. 
The reaction was quenched by adding 20% acetic acid into the reaction sample, and heating it for at 
90 °C for 10 min. A control (inactivated phosphatase) experiment was carried out by adding 20 μL 
of 20% acetic acid and heating at 90 °C for 10 min before adding the substrate, so that the 
phosphopeptide remained. The reaction and control samples were diluted and mixed in different 
phosphorylation fractions. 1 μL of 2.83 – 0.31 pmole peptide substrates was subjected to MALDI-
MS analysis.  
Isotope dilution MALDI-MS  
[13C3]-alanine labeled unphosphopeptide U* (AAA*AYRAAR) and labeled phosphopeptide 
P* (AAA*ApYRAAR) phosphorylated forms served as internal standards. The labeled standards 
were mixed with the unlabeled standards (U and P) in 1:1 ratio with the amount ranging from 0.1 -
20 pmole/µL and analyzed by MALDI-LTQ. The amount of P and U in unknown samples was 
determined by using calibration methodology. Calibration curves were constructed for each labeled 
pair by plotting signal ratios of labeled to unlabeled peptides versus their amount ratios (i.e. the 
signal ratios of P* to P versus their amount ratios; the signal ratios of U* to U versus their amount 
ratios) (2011 Kuklenyik).  
In vitro kinase assays 
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To investigate Cdk inhibitor’s activity, Cdk2/CyclinA was assayed using 1.4 μM HIV-1 RT 
peptide LRWGFTTPDKKHQKEPPF in the presence of 2 mM ATP and 1x NEBuffer (50 mM 
NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM DTT, New England BioLabs Inc.) at 30°C for 15 
min with the addition of Cdk inhibitors, Roscovitine at a concentration of 0.1 μM to 5 μM or 
Olomoucine, at a concentration of 1 μM to 50 μM. A control experiment was performed with no 
inhibitor addition. Following the incubation, 1 μL of each sample was added into 9 μL of the matrix 
solution for MALDI analysis. IC50 values are calculated by nonlinear regression analysis using 
GraphPad Prism (version 6 Prism Software Inc.). 
2.2.2 Results and Discussion 
MS is a fast, high-throughput, and probe-free method for phosphorylation quantification. 
Both HPLC-ESI-MS and MALDI-MS can be used for phosphorylation quantification. HPLC-ESI-
MS is considered to be more reproducible for phosphorylation quantification than MALDI-MS, 
even though MALDI is advantageous due to its analytical speed and accommodation of more 
complex samples. When used with isotope dilution quantitative strategy, MALDI-MS shows 
improved precision and reproducibility for peptide quantification, whereas isotope-free MALDI 
methods still face some challenges. For instance, phosphorylation may cause a change of ionization 
efficiency, which will result in non-linearity between the signal ratios and actual mole ratios. This 
condition has been previously observed in calibration curves for isotope-free MALDI-MS. To solve 
the problem requires considering the difference of ionization efficiencies in quantification. Here, we 
propose a new mathematic approach, called “Double Reciprocal Isotope-free Phosphopeptide 
Quantification (DRIP-Q)” to find a linear correlation between signals and actual amounts for 
phosphorylation quantification. 
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2.2.2.1 Mathematic Approach for phosphorylation quantification 
The DRIP-Q approach proposed here accounts for possible difference in ionization 
efficiencies for a phosphopeptide (P) and its unphosphorylated analog (U). It requires the 
assumption (which we later test experimentally) that signal intensity is directly proportional to 
sample concentration, where the proportionality constant is defined as the ionization efficiency, I.  
Therefore, 
 SP = IP × MP   (Eq. 1a) 
 SU = IU × MU (Eq. 1b) 
where S, I and M represent observed mass spectral signal intensity, ionization efficiency and amount 
in moles, and the subscript P or U  represents the phosphorylated peptide or its unphosphorylated 
analog. 
Eqs. 1a and 1b can be combined to give:  
𝑆𝑃
𝑆𝑈
 =  
𝐼𝑃
𝐼𝑈
𝑥
(1−𝑥)
  (Eq. 2a) 
where (x) is the mole fraction of phosphopepeptide P, and (1-x) is the mole fraction of U. For 
example, if xi=0.1, 10% of the total peptide is phosphorylated. 
Letting the signal ratio,  
𝑆𝑃
𝑆𝑈
= 𝑦, and the instrumental response factor ratio 
𝐼𝑃
𝐼𝑈
 = 𝑎, the equation 
becomes: 
𝑦 = 𝑎 ×  
𝑥
(1−𝑥)
  (Eq. 3b) 
Converting y = f(x) into x = f(y), yields: 
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𝑥 =  
𝑦
(𝑎+𝑦)
  (Eq. 3c) 
Taking the reciprocal of both sides of equation gives  
1
𝑥
 = 𝑎 ×  
1
𝑦
 + 1  (Eq. 3d) 
A plot of  
1
𝑥
  versus  
1
𝑦
  yields a straight line with a y-intercept of 1 and a slope of a. Therefore, once 
the response factor ratio, a, has been determined, the phosphorylation fraction x could be calculated 
by using the observed signal intensity ratio y of phospho- to unphospho-peptide. This method only 
requires determination of a and y, and therefore avoids time-consuming calibration curve 
construction. 
2.2.2.2 Consistency of instrument response factor, a 
For Eq. 3d to hold, the response factor ratio, a, must be constant. To investigate the linear 
correlation between the reciprocals of the phosphorylation percentage  
1
𝑥
  and signal ratios  
1
𝑦
  in Eq. 
3d, the response factor ratio was tested for three peptide models over a range of  phosphopeptide to 
unphosphosphopeptide concentration ratios. The three models (Table 2.1, data shown in Figure 
2.2, ) include peptides that may be phosphorylated at tyrosine, threonine or serine.  
For each model, the phosphopeptide and unphosphopeptide were mixed at nine different 
mole fractions of phosphopeptide (x), and the response factor ratio a was determined for each 
mixture from the observed mass spectrometric signal intensity ratio y. The response factor ratio is 
found to be consistent across the range of concentrations for each model (Table 2), with RSDs for 
a varying from 2.72% to 4.10% for the three models, confirming the linear correlation between  
1
𝑥
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and  
1
𝑦
  in Eq. 3d. These results demonstrate the potential for applying Eq. 3d to quantification of 
phosphorylation by isotope-free MALDI-MS.  
 
 
 
  
Table 2.1 Instrument response factor (a) at different phosphorylation fractions (x)
Instrumental Response Factor Ratio, a
xa 1b 2c xa 3ad 3bd
0.10 0.670  0.027 0.189  0.016 0.32 0.723  0.034 1.032  0.073
0.20 0.671  0.029 0.176  0.014 0.38 0.716  0.015 1.017  0.074
0.30 0.672  0.037 0.177  0.014 0.43 0.691  0.038 1.062  0.105
0.40 0.634  0.009 0.180  0.006 0.48 0.731  0.042 1.022  0.045
0.50 0.669  0.005 0.189  0.014 0.54 0.763  0.047 1.006  0.095
0.60 0.639  0.032 0.186  0.017 0.63 0.732  0.024 1.023  0.086
0.70 0.658  0.056 0.182  0.008 0.74 0.711  0.038 1.107  0.034
0.80 0.600  0.023 0.199  0.017 0.91 0.787  0.086 1.107  0.131
Average 0.652 0.184 0.733 1.047 
R.S.D.e 3.94% 4.32% 4.15% 3.86%
a phosphorylation fraction 
b peptide 1 and phosphopep. 1 (AAAAYRAAR, AAAApYRAA) within the range of 0.31 to 2.83 pmole
c peptide 2 and phosphopep.2 (LRWGFTTPDKKHQKEPPF, RWGFTpTPDKKHQKEPPF) within the range of 0.14 to 1.26 pmole
d peptide 3, phosphopeptide 3a, phosphopeptide 3b  (RQSVELHSPQSLPR, RQpSVELHSPQSLPR, RQSVELHpSPQSLPR) within the range of 10.0-90.0 fmole
e  n = 3
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2.2.2.3 Effect of laser energy on phosphorylation quantification 
MALDI mass spectrometric signal response may vary with laser intensity. Changes in the 
signal response might further affect the signal ratios (y) and the consistency of a values in Eq. 3d. 
For example, low laser intensity may lead to low signal response due to the deficiency in sample 
ionization, whereas excessively high laser intensity may produce a high signal background, lowering 
the signal to noise ratio. To investigate the effect of laser intensity on the constant a  in Eq. 3d, 
peptide 2 in its unphosphorylated and phosphorylated forms were mixed at various phosphorylation 
fractions (x), and  were analyzed by MALDI with laser energies of 8 and 13 µJ. For each mixture, 
the response factor ratio a value was calculated from the observed signal ratio (y) and the known 
phosphorylation fraction (x). Average a values were 0.23  5.70% RSD and 0.16  4.40% RSD for 8 
and 13 µJ, respectively (Table 2.2).  These results indicate that changes in laser intensity can 
differentially affect the ionization efficiencies of the un-phosphorylated and phosphorylated 
peptides, but the ionization efficiency ratio a is consistent with a small RSD at a constant laser 
energy across a wide range of phosphorylation fractions. As a result, care should be taken to ensure 
that the same laser intensity is applied to all samples in an experiment.  
To verify that phosphorylation fraction in a sample can be readily determined with the 
proposed DRIP-Q strategy, the phosphorylation fraction (x) calculation (Eq 3d) was assessed using 
the data already acquired as a test case. To do this, an experimental phosphorylation fraction was 
calculated for each sample by applying the observed peak ratio y and the average a value from Table 
2 to Eq 3d. This was done for both the 8 and 13 µJ laser energy samples. The experimental 
phosphorylation fractions were then compared to their known values, and accuracy determined as % 
error (Table 2), obtained on the basis of five experimental replicates per sample. The % errors for 
the experimental x values fall in the range of 0.07 % - 6.19 % (overall RMS error of 3.35%), and 0.52 
% - 5.33 % (RMS error of 2.43%), for 8 and 13 µJ laser energy, respectively. These error values 
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suggest that the ionization efficiency ratio a can indeed be applied to the Eq. 3d for accurate isotope-
free MALDI quantification of phosphorylation. 
 
 
2.2.2.4 Linearity, dynamic range and reproducibility 
After establishing consistency of the response factor a, across a wide range of 
phosphorylation fractions, in three different peptide models (Table 1), the same model peptides are 
further subjected to MALDI-MS analysis to investigate the linearity of the equation. The reciprocals 
of observed signal ratios (1/y) and the known phosphorylation fractions (1/x) are plotted in Figure 
2.3, and good linearity of Eq. 3d is shown among all peptide models with R2 values above 0.996. 
The dynamic range of the method is further determined by evaluating the consistency of the 
response factors (a) among pep 2 mixtures of unphosphorylated/ phosphorylated peptides (x = 0.5) 
with a serial dilution. A consistent signal ratio (1/y) was observed within a concentration range of 7 
to 0.04 pmole, shown in Table 2.3 (data shown in Figure 2.4). This suggests that the proposed 
Table 2.2 The effect of  different MALDI laser energy on the instrument response factor (α) and accuracy (% errors).
8 µJ 13 µJ
xa
Response factor ratio, 
a
x
(observed)
% error
Response factor ratio, 
a
x
(observed)
% error
0.090 0.226 0.017 0.088 -2.25 0.157  0.008 0.089 -0.89
0.110 0.215 0.015 0.103 -6.19 0.154  0.004 0.107 -2.73
0.140 0.217 0.013 0.133 -5.32 0.157  0.014 0.139 -0.64
0.200 0.231 0.010 0.200 -0.20 0.148  0.005 0.189 -5.33
0.330 0.231 0.012 0.330 -0.07 0.157  0.010 0.328 -0.52
0.670 0.244 0.016 0.682 1.79 0.164  0.002 0.678 1.24
0.800 0.255 0.011 0.815 1.89 0.172  0.007 0.812 1.55
Average 0.231 RMS (%)
3.35
Average 0.158 RMS (%)
2.43R.S.D. 5.70% R.S.D. 4.44%
a Phosphorylation fraction  of the Pep. 2 mixture of 0.13- 1.12 pmole
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DRIP-Q method is feasible for phosphorylation quantification with a dynamic range of at least two 
orders of magnitude, down to 40 fmol of sample on the plate.  At levels below this, the spot-to-spot 
variability in a increases to less reliable levels (not shown).  
 
 
 
  
  
A
C D
B
Figure 2.3. Linearity of double reciprocal equation. The linearity of the double 
reciprocal procedure is assessed by comparing the experimentally determined and calculated 
double reciprocal plots using phosphorylated and unphosphorylated analogs of (A) peptide 
1 (B) peptide 2  (C) peptide 3A and (D) peptide 3B 
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To investigate reproducibility, we conducted three experiments in separate days within a two 
week period under the same instrumental conditions. Figure 2.5 shows the plots of the 
concentration curves for analysis of the pep. 2 mixtrues with different phosphorylation fractions 
across the three experiments. Each of the curves was assigned a random range of phosphorylation 
fractions. Comparison of the curves demonstrates demonstrated good linearity, with R2 >0.99, and 
good agreement among the three concentration curves, with the mean slope of 0.186 and inter-day 
CV of 0.65% (n=3).  
 
 
 
 
Table 2.3 Effect of sample concentration on unphospho- to phospho signal ratio (Sun/Sp)
Amount a (pmole) Sun/Sp
7.0 6.94  0.35b
3.5 7.15  0.33
1.7 7.50  0.90
0.8 6.93  0.62
0.4 7.18   0.66
0.04 7.12  0.55
Average 7.14   0.21
RMS error 0.62
a the mixture of LRWGFTTPDKKHQKEPPF and LRWGFTpTPDKKHQKEPPF (x=0.5; 1:1, w/w) by 
using13 μJ laser energy
b standard deviation, n=3
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a) 7.0 pmole
b) 3.5 pmole
c) 1.7 pmole
d) 0.8 pmole
e) 0.4 pmole
f) 0.04 pmole
Figure 2.4 Mass spectra of the experiments for dynamic range test in Table 3. Pep 2/ 
p-pep 2 mixtures (LRWGFTTPDKKHQKEPPF/RWGFTpTPDKKHQKEPPF) with 
phosphorylation fraction (x = 0.5) in an amount range of 7.0 – 0.04 pmole were analyzed by 
MALDI-MS.  
Figure 2.5 Inter-day reproducibility Double reciprocal plots for peptide 2 obtained from three 
individual experiments performed on different days in a 2 week period  
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2.2.2.5 Validation of phosphorylation quantification by isotope dilution MALDI-MS 
The previous studies on model peptide systems demonstrate the ability to monitor the 
amount of phosphorylation in a sample using Eq. 3D. Because consistent a values can be obtained 
under a variety of conditions, the DRIP-Q method provides a rapid and low-cost strategy for 
phosphorylation quantification directly from the observed signal ratios and the a values without 
isotopes or chromatography. 
In order to validate the proposed DRIP-Q method, it was compared with isotope dilution 
MS, an established method previously shown to be a robust and precise quantitative MS platform 
for peptide analysis (2011 Kuklenyik). The isotope dilution strategy utilizes heavy stable isotope-
labeled internal standards that are otherwise identical to the analyte; because the analyte and 
isotopomeric standard have identical chemical structures, they do not suffer from the typical 
MALDI-related difficulties of heterogeneous crystal distribution and differential ionization. 
However, its effectiveness as a quantitative method is tempered by the need for cost of producing 
isotopically labeled standards. 
To compare the two methods, mixtures of a peptide 1, AAAAYRAAR and its 
phosphorylated form were mixed with 30% (w/w) and 40% (w/w) phosphorylation concentrations ( 
x = 0.3 and 0.4) were subjected to both methods. To perform the isotope dilution analysis, 
phosphorylated and unphosphorylated versions of peptide 1 were both synthesized with unlabeled 
or [13C3]-Alanine at the first position. The labeled and unlabeled peptides were mixed in defined 
amounts and subjected to MALDI analysis. The results of DRIP-Q method and isotope dilution 
MALDI-MS method are compared in Table 2.4.  
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The phosphorylation fraction of each peptide mixture samples was determined at 0.291 and 
0.394 in agreement with the results (0.295 and 0.391, p > 0.60) obtained from isotope dilution 
method. Quantification by isotope dilution yields a smaller standard deviation than the DRIP-Q 
method (1.7-1.8% RSD vs 4.3-6.3% RSD, p < 0.01), a result that could be expected since the use of 
isotopic internal standards eliminates some of the intrinsic uncertainty in MALDI quantification. 
Furthermore, other groups have reported average RSDs of 16.6% and 7.9 % for label-free ESI LC-
MS method and Isobaric Tags for Relative and Absolute Quantification (iTRAQ) method, 
respectively (2012 Wang). While ESI is thought to be more quantitatively reproducible than 
MALDI, the DRIP-Q method performs comparably to or better than these reported methods, 
possibly because the MALDI technique allows for longer acquisition time. In this analysis, spectra 
from approximately 18,000 laser shots were acquired over 5 minutes (laser firing at a repetition rate 
of 60 Hz), allowing for the averaging of much more data than typically available over the elution 
time of a peak in LC-MS; indeed MALDI shows substantial improvement in reproducibility as the 
number of laser shots increases (Figure 2.6).  A similar phenomenon is observed by Johnson et al. 
when evaluating the QconCAT isotope label-based phosphorylation stoichiometry methodology 
(2009 Johnson). For peptides analyzed by both MALDI and ESI, they observe RSDs of 1.1% - 
16.2% for MALDI and 2.0% - 30.5% for ESI, with MALDI ionization giving consistently more 
reproducible results. Together, these data suggest the variations between DRIP-Q method and 
Table  2.4 Comparison of  the results obtained by the proposed DRIP-Q method and isotope dilution 
method.
fraction (x) a DRIP-Q method Isotope dilution method p value b
0.3 0.291  0.018 0.295  0.005 0.58
0.4 0.394  0.017 0.391  0.005 0.63
a mixtures of AAAAYRAAR/AAAApYRAAR with phosphopeptide fraction (0.3, 0.4) in an amount range of  0.9- 2.0 pmole
b t-test (two tails, n=5)
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isotope dilution MALDI-MS method are comparable with excellent accuracy, in spite of no isotope 
labeling or calibration curve needed in the proposed DRIP-Q method. The somewhat better 
precision of isotope labeling does not lead to an obvious increase in accuracy, and is offset by the 
lower cost of the isotope-free DRIP-Q method. 
2.2.2.6 Applications 
This study provides a simple and accurate quantitative method to determine phosphorylation 
by MS, with potential applications for assessing kinase activity and inhibitor potency. Cyclin-
dependent kinases (Cdks) are proline-directed serine/threonine kinases that regulate eukaryotic cell 
cycle. Inhibitors of Cdks are currently under investigation as potential therapeutics for cancer and 
viral infection (2014 Holcakova, 2011 Cicenas). Here, the DRIP-Q method is evaluated as a method 
for assessing the in vitro inhibition of Cdks.   
r-Roscovitine and Olomoucine are well known pharmacological ATP-competitive inhibitors 
of Cdks. In a recent paper, r-Roscovitine has also been reported as a potential pharmacological Cdk 
inhibitor of HIV-1 replication, showing the higher selectivity in inhibiting HIV-1 infected cells than 
Olomoucine (2010 Guendel). Peptide 2 (LRWGFTTPDKKHQKEPPF) derived from HIV reverse 
transcriptase was subjected to in vitro phosphorylation by Cyclin A/Cdk2. After incubation of kinase, 
peptide and ATP, the reaction mixture was subjected to DRIP-Q analysis to determine the IC50 
(50% inhibition of the control) values of r-Roscovitine and Olomoucine. The mathematical a value 
for the system was determined using a single point measurement of phosphorylated and 
unphosphorylated standards (Figure 2.7A), and found to have a value of a = 0.184  0.017. This a 
value was then applied to peptide/phosphopeptide signal intensity ratios according to Eq. 3d 
without the construction of additional calibration curves. Inhibition plots were generated, and IC50s 
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of r-Roscovitine and Olomoucine were found to be 0.92  0.16 μM and 12.28  0.74 μM, 
respectively (Figure 7B).  
 
 
Figure 2.6 Variability in MALDI-TOF MS signal, as measured by the coefficient of variance of
the signal intensity ratios for either a non-isotopomeric (blue) or isotopomeric (red) peptide pair
decreases as a function of increased laser shots for both isotopomeric and non-isotopomeric
pairs. Spectra were acquired using a Waters MaldiMX MALDI-TOF mass spectrometer in
positive reflectron mode using unphosphorylated 13C3 labeled and unlabeled peptide 1 for the
isotopomeric pair, and unphosphorylated and phosphorylated unlabeled peptide 1 for the non-
isotopomeric pair. MALDI samples were prepared using the dried droplet method as previously
described using a 1 pmol 1:1:1 mixture of all three peptides (labeled, unlabeled and
phosphorylated) in a saturated solution (solvent 70:29.9:0.1 acetonitrle:water:TFA v/v/v) of
alpha-cyano, 4-hydroxycinnamic acid matrix. Spectra were acquired in manual mode using an N2
laser firing at 60 Hz.
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This suggests that both r-Roscovitine and Ololomoucine have low micromolar inhibitory 
activity against the substrate peptide2 in the presence of Cdk2/CyclinA. The inhibitory activity of r-
Roscovitine is about 10 times higher than Olomoucine for Cdk phosphorylation of peptide 2. Prior 
published studies report similar IC50 range of r-Roscovitine (0.65-1.8 μM) (1997 Meijer, 2005 Bach) 
and Olomoucine (7- 8.8 μM) (1994 Vesely, 2005 Raynaud) for Cdk2/CycA activity, consistent with 
the results that r-Roscovitine has also 10 times more inhibitory acitivity than Olomoucine. The 
consistency indicated that the proposed DRIP-Q method may have feasibility to provide a reference 
method for simply, fast and accurately quantify phosphorylation with kinase assays. 
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Figure 2.7 In vitro inhibition of Cdk2 measured by DRIP-Q method. (A) Mass spectra of 
mixture of phospho – and unphosphopeptide 2 (0.14 pmole) in a Cdk kinase buffer. The 
response factor ratio α was determined from the observed mass spectrometric signal intensity 
ratio, y =2.93, and the known phosphorylation fraction, x = 0.65 for the measurements of in 
vitro inhibition of Cdk2 phosphorylation of Peptide 2. (B) Inhibitory activities IC50 of 
Roscovitine and Olomoucine against Cdk2/cyclin A. Peptide 2 is used as substrate in in vitro 
kinase assays.  
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2.2.3 Conclusion 
 In this chapter 2.2, a novel quantitative strategy combined with isotope-free MALDI-MS to 
quantify phosphorylation in in-vitro assays is described. No calibration is required in this method. 
Based on the proposed DRIP-Q method, phosphorylation concentration in an assay sample was 
simply calculated by using its signal ratios on the mass spectrum with the consistent instrument 
response factor. Excellent reproducibility, precision, dynamic range and accuracy have been 
determined by using three different peptides, containing different phosphorylation sites (Serine, 
Threonine, and Tyrosine respectively). Method validation has been carried out by comparing DRIP-
Q method to an isotope-dilution method. In addition, the method has been successfully applied to 
an in vitro assay to monitor the inhibition activity of Cdk inhibitors by determining IC50 values.
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2.3 Label-free MALDI-MS for double-site phosphorylation quantification  
Many phosphorylation sites tend to be clustered in disordered or unfolded regions of 
functionally important protein domains (2007 Chang, 2012 Fisher). Holt et al. found, for example, 
that multiple Cdk1 phosphorylations at rapidly evolving site clusters appear to regulate the evolution 
of kinase-signaling circuits (2009, Holt). A gain or a loss of phosphorylation at individual 
phosphorylation sites may dynamically trigger a chain of events associated different protein 
functions and biological activities. For example, Aquaporin-2 (AQP-2) shows a significant increase 
in phosphorylation at Ser-256 in response to short-term vasopressin treatment but, in contrast to 
Ser-256, dephosphorylation of Ser-261 occurs upon treatment with vasopressin (2010 Xie, 2006 
Hoffert).  
MALDI-MS analysis may suffer from some problems when applied to identification and 
quantification of the isomeric AQP-2 phosphopeptides, phosphorylated at Ser-256 (pSer-256) and at 
Ser-261 (pSer-261). First, the precursor ions of the isomeric phosphopeptides have identical mass in 
the full scan MALDI-MS spectra. In addition, MS2 fragmentation of the precursor ions containing 
labile serine-/threonine phosphorylation sites by collision-induced dissociation (CID) generates 
primary abundant neutral losses of phosphoric acid (m/z 98), resulting in indistinguishable MS2 
spectra of the isomeric phosphopeptides. 
To solve the MS2 problem, Electron Capture Dissociation (ECD), developed by McLaffery 
et al. (1998 Zubarev), and Electron transfer dissociation (ETD) (2004 Syka), induced by Hunt et al., 
have been recently used in tandem MS to generate c- and z- fragments with cleavage sites at N-Cα 
bond of the peptide backbone via gas-phase radical process, and leave the side-chains intact (2014 
Collins). For phosphorylation analysis, ETD creates MS2 spectra with no loss of phosphoric acid 
that show distinguishable fragmentation patterns corresponding to the isomeric phosphopeptide 
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backbones, not the abundant neutral loss of phosphoric acid. However, a problem may occur in 
MALDI coupled to ETD is that singly charged peptide ions, the majority of MALDI generated ions, 
are not amenable to ETD fragmentation, which requires charge reduction. Moreover, ETD is more 
expensive than the common CID for the reason that peptides must react with a large number of free 
electrons for efficient fragmentation, and generally the ECD/ETD technique is coupled to a high-
resolution analyzer, like FT-ICR or Orbitrap for top-down analysis. 
Instead, economical CID-MS3 is proposed in the study as an alternative way to analyze two 
singly phosphorylated AQP2 peptides at pSer-256 by PKA and pSer-261 by Cdk kinase. Even 
though the MS2 of the phosphoAQP2 peptides contain a dominant peak arising from neutral loss of 
phosphoric acid, causing identical MS2 spectra of the pSer-256 and pSer-261 (shown in Figure 2.8), 
the following MS3 approach provides a platform where the neutral loss peak in MS2 is further 
fragmented resulting in the discrete fragment pat  terns of remaining peptide backbone of the 
isomeric phosphopeptides. As shown in Figure 2.9, MS3 spectra of pSer-256 and pSer-261 are 
disguisable with different intensity ratios of the MS3 fragment m/z 1297.75 to 1495.83. This chapter 
is to describe a label-free MALDI-CID-MS3 method for relative phosphorylation quantification to 
determine AQP2 phosphopeptides of two discrete phosphorylation sites (Ser-256 and Ser-261) by 
measuring the change in the intensity ratios of the MS3 fragments. 
2.3.1 Materials and methods 
Materials 
HPLC grade water, acetonitrile, and formic acid were purchased as HPLC grade from Fisher 
Scientific (Pittsburg, PA, USA). Synthetic AQP-2 peptide, RQSVELHSPQSLPR and its two 
phosphorylated forms at pSer-256 and pSer-261, RQpSVELHSPQSLPR and 
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RQSVELHpSPQSLPR, were purchased from Anaspec (Fremont, CA) for the quantitative method 
development.  
MALDI-MS preparation 
AQP-2 Peptide standards, RQSVELHSPQSLPR, and its phosphopeptides,  
RQpSVELHSPQSLPR, and RQSVELHpSPQSLPR were selected to establish the label-free 
MALDI-MS2 quantitative method. 1 μL of the sample mixtures of the unphospho- and 
phosphopeptide standards with various phosphorylation fractions was mixed with 9 μL of matrix 
solution of either a saturated aqueous solution of a-Cyano-4-hydroxycinnamic acid (CHCA) (Sigma-
Aldrich, St. Louis, MO, USA) in 0.1 % trifluoroacetic acid/acentonitrol (30/70, v/v) or 2,5-
Dihydroxybenzoic acid (DHB) (Acros Organics Morris Plains, NJ, USA)  mixed with water / 
acetonitrile (50/50, v/v) in a 1:4 ratio (v/v). Then, 1 μL of the peptide mixture with the matrix  
solution was spotted on a MALDI plate prior to MALDI-MS analysis.  
MALDI-MS/MS analysis 
MALDI-MS experiments were carried out on a Thermo LTQ XL linear ion trap mass 
spectrometer (Thermo Scientific) was equipped with a MALDI ion source. A nitrogen pulsed laser 
at 337 nm was used to ionize analytes. The intensities of the laser were set at 8 μJ for CHCA matrix 
samples and at 40 μJ for DHB matrix samples with automated spectrum filter (ASF) off, 10 
microscan/step. Automatic gain control (AGC) was set at 30000 for full scans and at 10000 for MSn 
scans to regulate the ion amount filled in the trap. The acquire time was set to 4 min with 14,400 
laser shots. One microscan was acquired per MS/MS spectrum. The protonated AQP-2 ion (parent 
ion) at m/z 1714 subjected to MS2 was isolated for CID with 20% normalized collision energy, an 
isolation window at 3 m/z,, an activation q at 0.25 and activation time of 30 ms. A subsequent MS3 
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event was triggered where one of the MS2 product ions at m/z 1616 was selected for CID with 25% 
or 40 % normalized collision energy. The data were processed by XcaliburTM 2.0.7 software. 
In vitro kinase assays 
To investigate the feasibility of the method, kinase assays were employed was assayed by 
incubating 1 μM AQP-2 peptides with and Cdk1/CyclinB and PKA in different concentration ratios 
(0.2 to 0.6 μM, and 0.5 to 0.3 μM for Cdk1/PKA)  in the presence of 20 mM ATP and 1x NEBuffer 
(50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM DTT, New England BioLabs Inc.) at 
30°C for in a time course (10, 30, 90 min). At each time point, 1 μL of each sample was added into 9 
μL of the matrix solution for MALDI analysis.  
2.3.2 Results and discussion 
2.3.2.1 Mass spectra of p- AQP-2 isomers (pSer-256 and pSer-261) 
 Phosphopeptide isomers of AQP-2 pSer-256 and pSer-261 have identical not only mass-to-
charge ratio but also CID-MS2 fragmentation. The CID-MS2 spectra (Figure 2.8) of the 
phosphorylated AQP-2 isomers show a dominant peak corresponding to a neutral loss of 
phosphoric acid due to the unstable O-P bond of serine/phosphate. This leads to no difference in 
MS2 fragment pattern that can be identified and used for quantification. To resolve the problem, we 
proposed to utilize MS3 technique to generate backbone MS3 fragments of pSer-256 and pSer-261, 
following the strong neutral loss. In Figure 2.9, a different pattern of m/z 1297 to m/z 1460 was 
observed in the MS3 spectra of the isomers. pSer-256 contained higher abundance of MS3 fragment 
of m/z 1297, corresponding to y*12 – 2NH3; the reason might be that unexpected phosphate 
rearrangement on residue 12 of pSer-256 in MS2 results in the labile structure of MS3 precursor ion, 
generating more neutral loss of NH3 around residue 12. 
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Figure 2.8 MS2 fragmentation of pSer-256 and pSer-261.  
Figure 2.9 MS3 fragmentation of pSer-256 and pSer-261.  
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2.3.2.2 Mathematic Approach for double phosphorylation site quantification 
 The method proposed for double phosphorylation quantification is based on the difference in 
intensity ratios of MS3 fragments (m/z1297 (f1) to m/z 1460 (f2)) of AQP-2 phosphopeptides (pSer-
256 and pSer-261). It requires the assumption that MS3 fragment ratios of individual 
phosphopeptide (α for pSer-256 and β for pSer-261) remain constant while the amount of the 
phosphopeptide changes. 
 The MS3 fragment ratios of pSer-256 and pSer-261 can be represented as: 
𝑓1p 256
𝑓2p 256
 = α (Eq. 1a) 
𝑓1𝑝261
𝑓2𝑝261
 = β (Eq. 1b) 
where f1p256  and f2p256 represent signal intensity of MS
3 fragments m/z1297 and m/z 1460, 
respectively for pSer-256; f1p261  and f2p261 for pSer-261.  
 Another assumption is that signal responses are directly proportional to sample 
concentrations. Therefore, taking the amount of phosphopeptides, A p256 and A p261 into account, 
f1p256, f2p256, f1p261, and f2p261 in Eqs. 1 can be represented as: 
f1p256 = α A p256   (Eq. 2a) 
f2p256 = A p256  (Eq. 2b) 
f1p261 = β A p261  (Eq. 2c) 
f2p261 = A p261 (Eq. 2d) 
where if A p256 = A p261, then f2p256 = f2p261 (which we has confirmed experimentally in Table 5) 
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In analyzing a mixture of pSer-256 and pSer-261, Eqs 2a-d can be combined and the MS3 fragments 
ratio ( 
𝑓1𝑚𝑖𝑥
𝑓2𝑚𝑖𝑥
 ) becomes: 
𝑓1𝑚𝑖𝑥
𝑓2𝑚𝑖𝑥
 = 
α  𝐴𝑝256 + β  𝐴𝑝261  
𝐴𝑝256 + 𝐴𝑝261
 (Eq. 3) 
where the  
𝑓1𝑚𝑖𝑥
𝑓2𝑚𝑖𝑥
 is proportional to sample amount fraction, either
 𝐴𝑝261  
𝐴𝑝256 + 𝐴𝑝261
 or 
 𝐴𝑝256  
𝐴𝑝256 + 𝐴𝑝261
. 
Letting the amount ratio  
𝐴256
𝐴261
 = x, and the MS3 fragments ratio ( 
𝑓1𝑚𝑖𝑥
𝑓2𝑚𝑖𝑥
 ) = Rmix, the equation 
becomes: 
𝑅𝑚𝑖𝑥  = 
α𝑥+ β 
𝑥+1
 (Eq. 4) 
 According to the proposed Eq. 4, the amount fraction of pSer-256 to pSer-261 can be 
calculated by using the constant MS3 fragment ratios α and β, obtained from analyzing pSer-256 and 
pSer-261 standards, and observed MS3 fragments ratio Rmix. In other words, this method only 
requires determination of α and β, and therefore avoids time-consuming calibration curve 
construction. 
 
  
Table 2.5 Normalized intensity of  MS3 fragments of  f1 and f2 for pSer-256 and pSer-261 AQP2 
phosphopeptides
2 μM 10 μM
f1 f2 f1 f2
m/z 1297 1459 1297 1459
pSer-261 48.93 33.89 47.74 32.54
pSer-256 29.4 34.03 29.02 33.53
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2.3.2.3 Assumptions for the proposed Eq. 4 
 In 2.3.2.1, we describe how the mathematic approach is established for double phosphorylation 
site quantification, but the proposed Eq. 4 requires two plausible assumptions: 1) It requires the 
assumption that MS3 fragment ratios of individual phosphopeptide (α for pSer-256 and β for pSer-
261) remain constant while the amount of the phosphopeptide changes; 2) signal responses are 
directly proportional to sample concentrations. With the proposed Eq. 4, the amount fraction (x) of 
pSer-256 to pSer-261 can be readily determined by applying the MS3 fragment ratio, α or β, for pSer-
256 or pSer-261 and the MS3 fragment ratio of a mixture shown on a mass spectrum (Rmix). To 
verify the mathematic approach with Eq. 4, the assumptions must be demonstrated.  
According to the assumption 1, for the Eq. 4 to hold, α and β must be constant. To 
investigate this, β of pSer-261 was evaluated by analyzing pSer-261 samples over a range of amount 
from 0.20 pmole to 1.00 pmole. According to the data in Table 2.6, the β value of pSer-261 is 
found to be consistent across the amount range with standard deviations varying from 0.012 to 
0.025. The overall RMS error for across the experimental β values is 0.013 (1.52% of the averaged β 
value). The consistency of the β value observed in agreement with our assumption for developing 
Eq. 4 that α and β values remain constant even when the amount of the phosphopeptide changes 
shows the potential for utilizing Eq. 4 to relative quantification of doublesite phosphorylation by 
using MALDI-MS3 without isotopes and calibration curves.  
After the consistency of α and β has been demonstrated, the next step is to investigate if signal 
responses are directly proportional to sample concentrations (assumption 2). To do this, pSer-256 
and pSer-261 are mixed into 11 mixtures with different amount fraction, e.g. 0% to 100% pSer-261, 
at two concentration ranges, 0.02-0.2 μM and 0.1- 1 μM, and subjected to MALDI- MS3 analysis. In 
the analysis, the changes in Rmix on mass spectra are expected to represent a linear correlation with 
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amount fraction change in pSer-261 in response to pSer-256 in a mixture. The observed Rmix and the 
known pSer-261 fraction in the mixtures (% pSer-261) are plotted in Figure 2.10, and good linearity 
is shown with R2 values above 0.99 across a wide range of concentration between 0.02 μM and 1 
μM.  
Taken together, the value of β appears to be constant even when the sample amount changes 
analyzed, according with assumption 1; the Rmix is response to a changing fraction of pSer-256 and 
pSer-261 in mixtures that accords with assumption 2. These data allow the availability to further 
evaluate the proposed Eq. 4 to be applied to MALDI-MS3 analysis for relative quantification of 
pSer-256 and pSer-261.  
 
 
 
 
Table 2.6 The effect of sample amounts on R261 consistency
Amount a (pmole) Ratiosb
0.20 0.885 ± 0.012
0.40 0.851 ± 0.005
0.60 0.862 ± 0.002
0.80 0.860 ± 0.007
1.00 0.885 ± 0.025
Average 0.869
RMS error 0.013
a. AQP-2 phosphopeptide Ser 261, RQSVELHpSPQSLPR
b. m/z 1297 to m/z 1460
c. n=3
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 2.3.2.4 Dynamic Range and Accuracy 
From the previous results, the β value stays unchanged when the amount of pSer-261 analyzed 
varies from 0.20 to 1.00 pmole. The remaining question to be resolved in the next piece of the 
research is the dynamic range of the proposed method by using Eq. 4. To determine the dynamic 
range of the method, the consistency of α of pSer-256 is evaluated by analyzing the pSer-256 
standards with a series dilution. A consistency of α was observed within a sample amount range of 1 
fmole to 10 pmole, even though R.S.D. was greater than 25 % as the sample amount is at 1 fmole 
(Table 2.7). This is because when the concentration is close to detection limit, leading to the spot-
to-spot variability in Rp261 increases to a less reliable level. Overall, the data suggest the method is 
feasible for double phosphorylation quantification with a dynamic range of at least 3 orders of 
magnitude, down to 1 fmole of sample on the plate.  
y = -0.0059x + 1.4662
R² = 0.9944
y = -0.0063x + 1.505
R² = 0.9902
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Figure 2.10 The linearity between amount fraction (%pSer-261) and Rmix  
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 To evaluate accuracy of the proposed method, two known mixtures of pSer-256 and pSer-261 
(45% and 55% pSer-261) were analyzed with the use of α and β, determined by using individual 
phosphopeptide standard under the same instrumental conditions. Also, to validate the proposed 
single point method, it was compared with a traditional method by generating calibration curve of % 
pSer-261 across a sample amount fraction of 0% - 100 % pSer-261. In Table 2.8, experimental % 
pSer-261 were determined at 46.14 and 54.00 % by using the calibration curve method and at 46.89 
and 54.49 % by using our proposed single-point method with the use Eq. 4. Both results are in 
agreement with the true values at 45 and 55 % pSer-261.  Together, the current proposed method 
and the conventional calibration curve method offer similar accuracy but the single-point method 
would be more convenient and less time-consuming than the calibration curve method.  
Table 2.7 Dynamic range of the constant (α)
Amount of  pSer-256 (pmole) α R.S.D.*
10 2.13 1%
1 2.14 1%
0.1 2.15 3%
0.01 2.14 6%
0.001 2.16 27%
* n= 5
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2.3.2.5 Effect of collision energy on double phosphorylation quantification 
 In tandem MS, different collision energies may vary fragmentation patterns that might 
further affect the availability of Eq. 4 when α, β, and observed Rmix are used to calculate the 
phosphopeptide fraction (x). Selected ions colliding with insufficient collision energy may lead to 
low abundance in MS3 fragments and the precursor ions remaining intact, whereas excessively high 
collision energy may produce a higher MS/MS efficiency but this may cause inconsistent break-
down of the precursor ion. To investigate the effect of collision energy on the Rmix values in 
response to phosphopeptide fraction (x), pSer-256 and pSer-261 were mixed with a range of sample 
amount fraction (e.g. 0% - 100 % pSer- 261), and subject to MALDI-MS3 with collision energy of 25 
and 40 C.E. (Figure 2.11).  Under the two different collision energies, Rmix observed on mass 
spectra show linearly proportional to the known sample amount fractions (x). Experimental sample 
amount fractions (xexp) were further calculated by using Eq. 4, the observed Rmix values, and the 
previously determined α and β. The values of xexp are in agreement with the known fractions (x) with 
less than 3% relative standard deviation (Table 2.9). An important thing to note is that the change 
in collision energy can differentially affect the values of α and β, but does not affect the linear 
correlation between the observed Rmix values and sample fractions – assumption 2 that our single-
pSer-261 %
Single-point
method
Calibration curve 
method
p valueb
45 46.89± 1.24 a 46.14 ± 1.22 0.25
55 54.49± 2.41 54.00± 2.39 0.41
a  n=3
b t-test (two-tails, n=3)
Table 2.8 Determination of  % pSer-261 by using the proposed single-point 
method and conventional calibration curve method.
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point method rests on. As a result, care should be taken to ensure that the same collision energy is 
applied to all samples in an experiment.  
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Table 2.9 Effect of  collision energies on the amount fractions, % pSer-261. 
Mixtures of  pSer-256 and pSer-261 are analyzed under the collision energy at 25 
and 40 C.E.
25 C.E 40 C.E.
p261 (%) calculated p261% calculated p261%
10 12.5 ± 0.2 7.7 ± 0.1
20 23.7 ± 0.5 22.7 ± 0.4
30 30.7 ± 0.7 30.4 ±0.6
40 43.7 ± 0.6 41.0 ± 0.5
50 50.9 ± 0.3 48.7 ± 1.1
60 65.7 ± 1.9 61.4 ± 2.4
70 72.4 ±1.4 70.2 ± 0.8
80 81.6 ± 2.5 80.4 ± 1.2
90 91.1 ±0.2 88.9 ± 1.5
25 26.4 ± 0.6 26.9 ± 0.3
65 66.7 ± 1.0 65.0 ± 1.1
Figure 2.11 The effect of collision energy on α, β and Rmix. 
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2.3.2.6 Applications to in vitro kinase assays 
This proposed method provides a simple and accurate MS3 quantitative method for 
phosphorylation quantification of aquporin-2 peptides, which can be phosphorylated at discrete 
phosphorylation sites, pSer-256 by c   (PKA) and pSer-261 by Cdk1/Cyclin B. It is important to 
distinguish and quantify the pSer-256 and pSer-261 phosphorylation since their phosphorylation 
regulation leads to different aquporin-2 protein function. For example, vasopressin mediated PKA 
monophosphorylation of AQP2 at Ser-256 has shown to be required to increase water permeability 
and water absorption of renal principal cells, but the adjacent phosphorylation of Ser-261, 
independent of Ser-256 phosphorylation, does not appear to affect AQP2 trafficking (2010 Moeller). 
The proposed single-point method has been demonstrated using Eq. 4 to measure 
phosphorylation fraction (x) when AQP-2 pSer-256 and pSer-261 are mixed. To evaluate how Eq. 4 
can also facilitate measurements of phosphorylation fraction of pSer-256 to pSer-261 in an in-vitro 
kinase assay, the AQP-2  peptides are  incubated with ATP in a presence of both PKA and Cdk 
enzymes with different ratios (14:5 and 5:7, PKA:Cdk) in a time course (10 -120 min). Figure 2.12 
displays change in pSer-261 at a low or high Cdk level in a time course (10 – 90 min). The results 
show elevated Ser-261 phosphorylation is observed with a high level of Cdk (5:7 ratio of PKA to 
Cdk) in comparison to the results with a low level of Cdk (14:5 ratio of PKA to Cdk). This indicates 
that the proposed method is feasible to provide a method for simply and quickly quantifying relative 
amounts of phosphorylation at different phosphorylation sites in in vitro kinase assays. 
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2.3.3 Conclusion 
An isotope-free, chromatography-free and calibration curve-free tandem MS3 method has 
been proposed for relative quantification of AQP-2 double-site phosphorylation. The signal ratios of 
phosphopeptide MS3 fragments have been shown to be directly proportional to their relative 
amount fractions in a mixture of AQP2 phosphopeptides (pSer-256 and pSer-261). The values of α 
and β has further demonstrated to be consistent with the change in sample concentration. A wide 
analytical dynamic range (0.01-10 pmole) was shown by analyzing pSer-256 with a constant β value 
observed with good precision (<6% R.S.D). The accuracy of proposed the single-point method was 
demonstrated in comparison with calibration construction. Furthermore, the method is shown to be 
feasible to monitor changes in phosphorylation at differing phosphorylation sites in kinase assays. 
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Figure 2.12 Phosphorylation quantification of AQP-2 treated with PKA and Cdk in a 
time course. 
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Chapter 3: Investigation of Cdk phosphorylation in HIV-1 reverse transcriptase by mass 
spectrometry 
3.1 Introduction 
3.2 Materials and methods 
3.3 Results and discussion 
3.3.1 Host Cdks support HIV-1 reverse transcription in CD4+ T cells 
3.3.2 HIV-1 RT is a substrate for Cdk2-dependent phosphorylation 
3.3.3 Substitution of T216 by Alanine reduces HIV-1 RT 
3.3.4 Quantification of HIV-1 in vitro Cdk2-dependent phosphorylation 
3.3.5 Cdk2-dependent phosphorylation increases function and stability of HIV-1 RT 
3.3.6 p21 (waf-1/cip-1) suppresses Cdk2-dependent HIV-1 RT phosphorylation  
3.4 Discussions and conclusion 
 
 
3.1 Introduction 
CD4+T cells are the primary HIV target cells that represent different levels of susceptibility to 
HIV-1 among a variety of HIV-1 infected persons. The difference in susceptibility appears to be 
related to host specificity of HIV-1 viruses (2004 Ciuffi; 1995 Spira). Thus, a focus of HIV research 
has been on identification of relative absence or presence of specific host proteins that modulate the 
efficiency of HIV-1 replication by inhibiting specific steps of the viral life cycle. Over the recent 
years, there are several host proteins have been identified, but the virus-host protein interaction 
network in HIV-1 infected persons still remain unclear (2012 Harris; 2012 Malim). 
The host factors may play a dominant role in elite controllers, a small population of HIV-1 
infected persons with ability to suppress HIV-1 replication and maintain an undetectable virus level 
in the absence of antiretroviral therapy. Interesting, in 2011, a significantly reduced susceptibility of 
host CD4+T cells to HIV-1 has demonstrated in two geographically distinct cohorts of the elite 
controllers (2011 Chen; 2011 Saez-Cirion). This indicates that specific host proteins may reduce viral 
replication steps in the elite controllers and contribute to a CD4+ T cell-intrinsic mechanism of 
HIV-1 immune defense. Some classical HIV-1 host factors, such as APOBEC3G, TRIM5α and 
BST2, exert direct inhibitory effects on HIV-1 replication in HIV-1 progressors, but reduced 
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expression levels of the factors have been observed in CD4+ T cells in elite controllers; these known 
factors are unlikely involved in low susceptibility of host CD4+ T cells to HIV-1 infection (2013 
Abdel-Mohsen; 2009 Rotger; 2011 Vigneault). 
Our collaborators, Lichterfeld et al., have found that a protein called p21 (cip-1/waf-1), a host 
protein from the cyclin-dependent kinases inhibitor (CDKI) family, to be uniquely unregulated in 
CD4+ T cells from many elite controllers, compared to both HIV-1 negative persons and individuals 
with progressive infection (2011 Chen). Besides, knockout studies have shown that p21 inhibits 
HIV-1 replication inhibition in CD4+ T cells (2011 Chen), hematopoietic stem cells (2007 Zhang), 
and macrophages (2013 Allouch), although the underlying mechanisms for HIV-1 restriction seem 
to vary in each of these cell populations. According to Lichterfeld, after knocking out p21 by 
siRNA, the susceptibility to HIV-1 significantly increases. More interestingly, the resistance was due 
to less effective reverse transcription of HIV-1 and HIV mRNA transcription from proviral DNA 
(2011 Chen). 
One proposed hypothesis is that instead of blocking HIV-1 replication by directly interacting 
with virus proteins, the host p21 protein may indirectly block HIV-1 replication through reducing 
the functional activity of HIV-1 dependency factors, cyclin-dependent kinases (Cdks). In this 
project, we show that HIV-1 reverse transcriptase (RT) is a substrate for Cdk2-dependent 
phosphorylation at a highly conserved Thr 216 residue on the p66 domain (between the finger and 
palm subdomains) and on the domains p51, the structure shown in Figure 3.1. The Cdk2 
phosphorylation of RT is demonstrated to be functionally relevant for maintaining RT activity, 
stability and viral fitness, and can be effectively blocked by p21. Thus these data suggested a novel, 
indirect mechanism for inhibition of HIV-1 reverse transcription by the human host protein p21 
indirectly blocking Cdk2 phosphorylation of HIV-1 RT in elite controllers. 
 74 
 
 
 
 
3.2 Materials and methods 
In vitro kinase assays.  5μM HIV-1 RT peptides or RT proteins were subjected to a kinase assay in 
the presence of 1x NEBuffer (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, and 1 mM DTT, New 
England BioLabs Inc.) and incubated with 2 mM ATP and 550nM of indicated recombinant Cdk 
(Life Technologies) at 30°C for 1 or 3 h, as indicated. The kinase reaction was stopped by addition 
of SDS-PAGE loading buffer. Subsequently, proteins or peptides were analyzed by western blot or 
mass spectrometry.  
Peptide analysis. Mass spectrometric analysis of ex-vivo kinase assay products was performed by a 
Thermo LTQ XL linear ion trap mass spectrometer (Thermo Scientific) equipped with a vacuum 
MALDI source. Synthetic HIV-1 RT peptide samples were mixed with saturated α-Cyano-4-
hydroxycinnamic acid, CHCA (Sigma-Aldrich) in 0.1% trifluoroacetic acid: acetonitrile (70:30, v/v). 
Figure 3.1 The crystal structure of HIV-1 RT complexes with ds-DNA. HIV-1 RT is a 
heterodimer  composed of the following two domains p66 and p51. The active sites are on the p66 
domain containing the subdomains called fingers (blue), palm (red), thumb (green), and RNase H 
(orange). The p51 domain, a proteolytic cleavage product of p66, has a structural role in stabilizing 
the structure of RT. (Singh 2010) 
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A 1.0 µL aliquot of sample/matrix mixture was dispensed onto the MALDI plate, and the solvent 
evaporated at room temperature.  
In gel digestion.  RT samples separated by NuPAGE and the protein bands were cut out and 
digested by lysyl endopeptidase (Lys-C, Promega) at 37 °C for 4 h. The enzyme Lys-C was added to 
a final substrate-to-enzyme ratio of 40:1 with 50 mM ammonium bicarbonate, pH 8.5. After 
digestion, POROS 20 R2 resin (Applied Biosystems) was added into the digested RT samples for 
extraction at 4°C for 4h.  Prior to MALDI mass spectrometric analysis, the digests were desalted 
using ZipTip (Millipore) and eluted with CHCA MALDI matrix solution from resins directly onto a 
MALDI plate, and analyzed in single-stage, MS2 and MS3 modes. Protein bands were identified using 
Mascot (Matrix Science, Boston, MA). Identification of phosphopeptide peaks and interpretation of 
MS2 and MS
3 spectra was performed manually, with the assistance of PAWS sequence analysis 
software (Genomic Solutions, Winnipeg, CA) and ProteinInfo (Rockefeller University, NY; 
http://prowl.rockefeller.edu) to calculate theoretical molecular weights. 
Western blots. Protein lysates were prepared from cells infected with indicated viral constructs for 
48 hours, using Radio-Immunoprecipitation assay buffer (Sigma) supplemented with the Halt 
protease and phosphatase inhibitor cocktail (Pierce). Following denaturation at 95°C for 10 minutes, 
samples were resolved on NuPAGE Bis-Tris 4-12% gels (Invitrogen), electroblotted to PVDF 
membranes (Life Technologies) and blocked with bovine serum albumin (Sigma). Blots were 
hybridized with monoclonal antibodies against indicated proteins (p21: clone C-19 (Santa Cruz) 
1:1000 dilution; Cdk1: clone 5A6 (Thermo Scientific) 1:1000 dilution, Cdk4: clone PA5-14445 
(Thermo Scientific) 1:1000, Cdk9: clone: PA5-19674 (Thermo Scientific) 1:250, Cdk2: clone 78B2 
(Cell Signaling) 1:1000 dilution, Cdk7: clone MO1 (Cell Signaling) 1:2000 dilution, Lamin B1: ). For 
detection of phosphorylated HIV-1 reverse transcriptase, blots were hybridized with antibodies 
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against phosphorylated HIV-1 reverse transcriptase (1:800 dilution), generated by vaccination of 
rabbits with the phosphorylated target peptide (LRWGFTpTPDKKHQKEPPF) according to 
standard procedures by a commercial manufacturer (ThermoFisher Scientific). Selective reactivity 
against the phosphorylated target peptide, and not against the corresponding unphosphorylated 
peptide, was confirmed by Elisa assays. Detection of non-phosphorylated HIV-1 RT was performed 
using a commercially available antibody (1:2000 dilution, AB63911 (Abcam)). Control hybridizations 
were performed with a β-actin–specific antibody (1:5000 dilution, clone AB8224, Abcam). After 
washing, membranes were probed with Cy5-labeled secondary antibody at 1:2500 dilution (ECL 
Plex, GE Healthcare) for 1 h for chemifluorescence detection by Typhoon 9410 (Amersham 
Biosciences), using excitation/emission wavelengths of 649/670. Alternatively, signals were 
visualized using secondary goat-anti-rabbit antibodies labeled with IRDye 800CW, followed by 
quantification of signals using Odyssey Image System (Li-Cor) and Image J software (NIH).  
Determination of HIV-1 RT Stability. Recombinant HIV-1 RT was phosphorylated by a Cdk 
kinase assay followed by limited proteolysis with subtilisin (Sigma-Aldrich). The 0.16 mg/ml RT 
samples were incubated with subtilisin protease (1 mg/ml) in 100 mM Tris (pH 8.5) buffer at 30_C 
for 2, 30, 60, 120, 180, or 240 min (Serrano et al., 1984). For analysis, the collected samples were 
heate   d with SDS sample buffer at 90 °C, alkylated with iodoacetamide, and separated by SDS gel 
electrophoresis. Then, the gels were fixed in 40% methanol and 10% glacial acetic acid for 1 hr and 
stained with SYPRO Ruby Protein Gel Stain (Life Technologies) under dark conditions overnight. 
After being washed twice in 10% methanol and 7% glacial acetic acid for 1 hr, the stained gels were 
scanned on a Typhoon 9410 Imager with a green 532 nm excitation laser and 610BP30 emission 
filter. Densitometry quantification was performed with ImageQuant software (Molecular Dynamics). 
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Functional Assessment of HIV-1 RT. After in vitro kinase assays, 0.25 U of RT and phospho-RT 
were analyzed with the EnzCheck RT assay (Life Technologies). The HIV-1 RTs were incubated 
with 0.125 mg/ml Oligo d(T)16 primer, 2.5 mg/ml poly(A) ribonucleotide template, and 5 mM 
dTTP at room temperature for 10, 20, and 30 minutes. The reaction was quenched by adding 
EDTA, and the RT activity was measured with a fluorometric assay. 
Statistical Analysis. Data are expressed as mean and SD or SEM or as box and whisker plots 
indicating the median, the 25% and 75% percentile and the minimum and maximum of all data. 
Differences between different cohorts or different experimental conditions were tested for statistical 
significance with paired or unpaired Student’s t tests as appropriate. A p value of 0.05 was 
considered significant. 
Patients. Peripheral blood mononuclear cells (PBMCs) from HIV-1-infected individuals and HIV-
1-negative individuals were used for this study according to protocols approved by the Institutional 
Review Board of the Massachusetts General Hospital. All study subjects gave written consent to 
participate. 
HIV-1 Viruses and Constructs. The -encoding R5-tropic and VSV-G-pseudotyped HIV-1 
plasmids were kindly provided by Dr. Dan R. Littman (New York University). Viral particles were 
produced by transfecting human embryonic kidney 293T (HEK293T) cells (NIH AIDS Reagent 
Program) with the respective HIV-1 plasmids, and, if applicable, pCG-VSV-G, using TransIT-293 
(Mirus) in OptiMEM. R5-tropic or VSVG- pseudotyped viral variants encoding for a T216A 
mutation, were generated by site-directed mutagenesis by a commercial supplier (Genewiz); the 
correct sequence of the variant constructs was confirmed by repeated viral sequencing. Supernatants 
containing infectious retroviruses were harvested 48 hr after transfection, centrifuged, and filtered. 
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Viral titers were determined by measuring p24 levels in the supernatant of infected HEK293T cells, 
and confirmed by measuring TCID50 levels in TZM-bl cells (NIH AIDS Reagent Program). 
In Vitro Infection Assays. PBMCs were stimulated in RPMI medium containing 10% fetal calf 
serum (FCS), recombinant IL-2 (50 U/ml), and an anti-CD3/CD8 bispecific antibody (0.5 mg/ml). 
A homogenous population of activated CD4+ T cells was infected on day 5 with the indicated HIV-
1 viruses for 4h (R5) or 2h (VSV-G) at 37_C. After two washes, cells were resuspended and plated 
at 13106 cells per well in a 24-well plate. The CD4+ T cells were subjected to flow cytometric 
analysis of GFP+ CD4+ T cells at 96 hr after infection with GFP-encoding R5-tropic HIV-1 or 48 
hr after infection with VSV-G-pseudotyped HIV-1 virus. When indicated, proteasome inhibitors 
(MG-132, Millipore) were added at a concentration of 1mg/ml. For replication capacity assays, 
CD4+ T cells were infected with either WT or T216A-variant R5-tropic HIV-1 viruses. At indicated 
time intervals, supernatants were analyzed by p24 ELISA kit (PerkinElmer). Replication capacities 
were calculated by fitting a linear model to the log-transformed p24 concentration with maximum 
likelihood models. 
siRNA-Mediated Gene Knockdown. CD4+ T cells were suspended in 100 ml transfection 
solution (Lonza), and target-specific or control siRNA (Dharmacon) was added at a concentration 
of 4 nmol/ml. Then, samples were transferred into nucleofection cuvettes and transfected with T-
023 in a Nucleofector device (Lonza). Afterwards, cells were resuspended in medium supplemented 
with 20% FCS; IL-2 (50 U/ml) was added 2 hr after transfection. Cells were infected with indicated 
HIV-1 strains at 24 hr after transfection. 
Flow Cytometry. The proportion of CD3+ CD4+ GFP-positive cells was analyzed on an LSRII 
flow cytometer (BD Biosciences), and data analysis was performed with FlowJo software (TreeStar). 
For imaging flow cytometry experiments, PBMCs were stained with antibodies directed against CD3 
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and CD4, fixed, and permeabilized. Subsequently, intracellular staining was performed with p21-
specific antibodies (clone F-5, Santa Cruz Biotechnology). The samples were run on an ImageStream 
Cytometer (Amnis), and data visualization and colocalization analysis were performed with IDEAS 
Software (Amnis). 
Detection of HIV-1 Reverse Transcripts. Cells were harvested 18 hr after infection of activated 
cells with VSV-G-pseudotyped HIV-1 and 48 hr after infection of activated cells with R5-tropic 
HIV-1. RT products were amplified from cell lysates with primers and probes hRU5- F2, hRU5-R, 
hRU5-P (early RT transcripts), FST-F1, SS-R4, P-HUS-SS1 (intermediated RT transcripts) and 
GagF1, GagR1, and P-HUS-103 (late RT transcripts) (Mbisa et al., 2009). CCR5 was amplified as a 
housekeeping gene and used for the quantification of input cell numbers (2011 Chen). Serial 
dilutions of DNA from cell lysates of the HIV-1-infected cell line HEK293T (provided by Dr. 
Frederic Bushman, University of Pennsylvania) were used for reference purposes. 
Coimmunoprecipitation Assays. Protein lysates from CD4+ T cells were incubated in spin 
columns coated with anti-Cdk2 (clone 78B2; Cell Signaling) for 12 hr at 4°C. After washing, protein 
complexes were eluted, boiled, and subjected to SDS-PAGE followed by western blotting with 
antibodies against HIV-1 RT (AB63911; Abcam), cyclin A (clone BF683; Cell Signaling), and cyclin 
T (clone 8744; Cell Signaling). 
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3.3 Results and discussion 
3.3.1 Host Cdks support HIV-1 reverse transcription in CD4+ T cells 
 In Lichterfeld’s recent study, p21 has been found to be associated with the reduction in 
HIV-1 susceptibility due to less effective reverse transcription, in which Cdks may be important for 
activating RT, and this process is inhibited by p21. To investigate how Cdks play a recognized role 
in reverse transcription during the HIV-1 life cycle, the influence of pharmacological Cdk inhibition 
on reverse transcription in CD4+ T cells was first studied. Primary CD4+ T cells from HIV-1 
negative persons were ex-vivo activated with CD3/CD8 bi-specific antibodies and IL-2, followed by 
infection with a GFP-encoding R5-tropic HIV-1 or VSV-G-pseudotyped HIV-1 virus construct in 
the presence or absence of Roscovitine or Olomoucine, two chemical inhibitors of Cdks. These 
experiments in Figure 3.2A-C demonstrated that pharmacological inhibition of Cdks effectively 
reduced the proportion of GFP-positive CD4+ T cells, and the per-cell levels of early HIV-1 reverse 
transcripts (minus-strand strong-stop DNA), intermediate HIV-1 reverse transcripts (minus strand 
DNA) and late, double-stranded HIV-1 reverse transcription products; similar observations were 
made when cells were infected with GFP-encoding VSV-G pseudotyped HIV-1 virus that cuases 
single-round infections of CD4+ T cells independently of viral coreceptors (Figure 3.2D-F). 
Altogether, these data strongly indicate blockade of HIV-1 reverse transcription by pharmacological 
Cdk inhibitors in infected cells with either GFP-encoding R5-tropic HIV-1 or VSV-G-pseudotyped 
HIV-1 virus construct, therefore, Cdks might be required for HIV-1 reverse transcription and it is of 
interest to better understand the role of the host Cdks, the target molecules for Roscovitine and 
Olomoucine, in supporting HIV-1 reverse transcription. 
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Figure 3.2 Host CDK supports HIV-1 reverse transcription. Activated CD4+ T cells were 
infected ex vivo with GFP-encoding, R5-tropic HIV-1, or GFP-encoding VSV-G-pseudotyped 
HIV-1 in the presence or absence of the pharmaceutical CDK inhibitors Roscovitine and 
Olomoucine. (A/D ) Representative flow cytometry plots showing infected GFP+ CD4+ cells. 
(B/E) Proportions of GFP+ CD4+ T cells after exposure to indicated CDK inhibitors. (C/F) 
Quantitative analysis of early, intermediate, and late HIV-1 RT transcripts in CD4+ T cells from 
the indicated study groups. All statistical comparisons were performed with Student’s t tests. 
*p<0.05; **p<0.01; ***p<0.001. Data are expressed as box and whisker plots indicating the 
median, 25% and 75% percentile, and minimum and maximum of all data. These results were 
generated by Jin Leng at MGH. (2014 Leng) 
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3.3.2 HIV-1 RT is a substrate for Cdk2-dependent phosphorylation  
 HIV-1 gene products can represent direct targets for phosphorylation by host kinases (2011 
Francis). We hypothesized that Cdk2 can support HIV-1 reverse transcription through 
phosphorylation of HIV-1 RT, a key enzyme of reverse transcription of viral RNA into dsDNA, 
which can further be inserted into host DNA genomes and copied by human machine, leading to 
massive damage to the host cells. Cdks are requisite proline-directed serine/threonine kinases with 
preference for basic amino acids located c-terminal to the phosphate acceptor (1993 Nigg); therefore 
the canonical Cdk substrate motif is S/T-P-X-R/K, where X can be any amino acid(s). The HIV-1 
RT protein contains seven such Cdk motifs (Figure 3.3).  
 
 
 Synthetic peptides were generated with sequences derived from these motifs and their 
surrounding amino acids for an initial rapid screen of potential Cdk phosphorylation sites. Each of 
Figure 3.3 HIV-1 reverse transcriptase sequence. Seven minimal Cdk phosphorylation 
consensus motifs (S/T)P are highlighted in red in the HIV-1 reverse transcriptase sequence.  
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these peptides was assayed as a Cdk substrate by incubating with ATP and Cdk2/cyclin A, 
Cdk2/cyclin E, Cdk7/cyclin H or Cdk9/cyclin T1 (Figure 3.4A), followed by mass spectrometric 
analysis.  Robust phosphorylation of the synthetic peptide containing the motif at Thr216 
(corresponding to HIV-1 RT amino acid residues [210-227]) was observed using both Cdk2/cyclin 
A and Cdk2/cyclin E, and trace phosphorylation was observed at two other peptides with 
Cdk2/cyclin A (Figure 3.4A). Phosphorylation was not observed with any other HIV-1 RT peptides 
harboring Cdk phosphorylation motifs (data not shown). When the [210-227] peptide was incubated 
with Cdk2/cyclin A for 0, 1 and 2 hours, a time-dependent increase in mass spectral signal at +80 
mass units (corresponding to covalent addition of HPO3) was observed (Figure 3.4B).  When 
similar assays were performed using Cdk7 or Cdk9, the positive control peptide, but no 
phosphorylation of the [210-227] peptide or any other HIV-1 RT peptides, were observed (Figure 
3.5). These findings suggest that phosphorylation of HIV-1 RT occurs site-specifically at Thr216 by 
only Cdk2 kinases in vitro. Although Cks1 protein was not used in the in vitro assay, it does not 
change the importance of Cdk2 phosphorylation site that is necessary to be phosphorylated prior to 
Cks induced multiple phosphorylation.  
 Figure 3.4 HIV-1 RT is a substrate for Cdk2-dependent phosphorylation. (A): Level of 
phosphorylation observed by semi-quantitative MALDI mass spectrometry on synthetic peptides 
derived from HIV-1 RT after incubation with indicated Cdks and ATP for 3 hours. “+” denotes 
phosphopeptide levels < 1-25%; “++” indicates phosphopeptide levels of 25%-50%; “+++” 
reflects phosphopeptide levels >50% of total peptide signal intensity. (B): Time course for in vitro 
phosphorylation reaction of synthetic peptide [210-227] incubated with ATP and cyclin A/Cdk2, 
assayed by MALDI-selected ion monitoring mass spectrometry.  
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Lichterfeld’s group further conducted ex-vivo infection experiments of CD4+ T cells after 
siRNA-mediated knockdown of Cdk2 and Cdk7 in the cytoplasm of CD4+ T R5-tropic or VSV-G-
pseudotyped infected cells where HIV-1 reverse transcription occurs. A significant reduction of 
proportion of HIV-1 positive cells, and of the frequency of per-cell levels of early, intermediate and 
late HIV-1 reverse transcripts has only been observed with the down-regulation of Cdk2, but not of 
Cdk7 (Figure 3.6). Of note, silencing of Cdk9 slightly reduced cellular susceptibility to productive 
HIV-1 infection, consistent with previous findings (1999 Flores), but had no effect on viral reverse 
transcription (Figure 3.7). The findings indicate that Cdk2 is critical for supporting HIV-1 reverse 
transcription in CD4+ T cells, corresponding to our prior in vitro observation that HIV-RT has a 
selective susceptibility to phosphorylation by Cdk2. 
 
Figure 3.5 In vitro phosphorylation reaction of synthetic peptide [210-227] by 
cyclindependent kinases. The peptide [210-227] was incubated with ATP and cyclin H/Cdk7, 
cyclin T1/Cdk9, or cyclin E/Cdk2 for 3 hours, and assayed by MALDI-selected ion monitoring 
mass spectrometry. Phosphorylation is not observed for Cdk7 or Cdk9. Dyrktide was used as a 
positive control. 
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Figure 3.6 Cdk2 supports HIV-1 reverse transcription. (A/D): Representative flow cytometry 
plots showing infected GFP+ CD4+ cells. (B/E): Proportions of GFP+ CD4+ T cells after exposure 
to indicated Cdk inhibitors or Cdk-directed siRNAs.  (C/F): Quantitative analysis of early, 
intermediate and late HIV-1 RT transcripts in CD4+ T cells from the indicated study groups. All 
statistical comparisons were performed using Student’s t tests. *, p<0.05. **, p<0.01. ***, p<0.001. 
These results were generated by Jin Leng at MGH. (2014 Leng) 
Figure 3.7 Influence of Cdk1, Cdk4 and Cdk9 on HIV-1 replication. (A-B): Infection of CD4+ T 
cells from HIV-1 negative persons with R5-tropic (A) or VSV-G-pseudotyped (B) HIV-1 in the 
presence of indicated siRNA. (C-D): Corresponding analysis of HIV-1 reverse transcripts in CD4+ 
T cells after experimental knock-down of Cdk9. These results were generated by Jin Leng at MGH. 
(2014 Leng) 
 86 
To further investigate the Cdk2 phosphorylation site at Thr216, the Cdk2- phosphorylated 
[210-227] peptide was subjected to tandem mass spectrometry (MS2). Specific fragmentation of the 
phosphorylated peptide showed a strong signal at -98 mass units from the parent peptide peak, 
corresponding to the neutral loss of phosphoric acid, a diagnostic characteristic of Ser/Thr 
phosphorylated peptide ions (Figure 3.8). Furthermore, using backbone fragmentation, we found 
that the y11 fragment ion, which runs from Pro217 to Phe227 and does not contain Thr216, is 
observed at a mass indicating no phosphate. In contrast, the y12 fragment ion, which runs from 
Thr216 to Phe227, is observed at a mass indicating the presence of a phosphate adduct (Figure 3.8). 
Because the two fragments both arise from the singly phosphorylated [210-227] peptide, and are 
identical in amino acid sequence except for the Thr216 residue that is selectively contained in the y12 
fragment ion, these data indicate that Thr216 is indeed the Cdk2 phosphorylation site (Figure 3.8). 
Since the data suggested that Thr216 represents the only site in HIV-1 RT susceptible to 
Cdk-dependent phosphorylation, we performed phosphorylation analyses on the intact HIV-1 RT 
protein. Recombinant HIV-1 RT protein was phosphorylated in vitro and subjected to analysis using 
western blots. For this purpose, we generated rabbit-derived antibodies that specifically recognized 
the HIV-1 RT [210-227] peptide sequence phosphorylated at position Thr216. In western blot 
experiments, two RT bands (p51 and p66 subunits) were detected with anti-[phospho-210-227] 
antibodies after incubation with ATP and Cdk2/Cyclin A for 30 min (Figure 3.9A). An increase in 
the intensity of the phospho-RT bands was observed after incubation for 120 min. To conclusively 
determine the phosphorylation site in the RT protein, phosphorylated HIV-1 RT was digested by 
endoproteinase Lys-C and the digests were analyzed by mass spectrometry. A mass spectral peak at 
m/z 2413 was observed in the spectrum arising from the Cdk2-phosphorylated but not the 
unphosphorylated HIV-1 RT digest. This peak corresponds to the phosphorylated Lys-C peptide 
[202-220], containing the Thr216 Cdk phosphorylation site (Figure 3.9B, bottom panel). 
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Phosphorylation at Thr216 was confirmed by MS2 and MS3 fragmentation (Figure 3.10). In 
contrast, the spectrum of the unphosphorylated HIV-RT digest contained a significant peak at m/z 
2334 corresponding to un-phosphorylated peptide [202-220] (Figure 3.9B, top panel); that peak 
appears substantially weaker in the spectrum from the Cdk2-phopsphorylated RT digest. No other 
peaks corresponding to phosphorylation at Cdk consensus motifs were observed in either digest 
(data not shown). Together, these data strongly indicate Cdk2-dependent phosphorylation 
specifically at Thr216 in HIV-1 RT.  
We subsequently analyzed the structural position of the targeted Thr216 residue, using prior 
crystal structures of HIV-1 RT (1994 Jager; 1992 Kohlstaedt). We observed that Thr216 lies in β 
strand 11 for both the p51 and p66 subunits, situated near the interface between the fingers and 
palm of the structure (Figure 3.11A). This solvent-exposed position of Thr216 at the molecular 
surface is consistent with its role as a target for cytoplasmic host kinases. In addition, we found that 
the targeted Cdk phosphorylation motif (Thr216 and adjacent Pro217) was highly conserved across 
more than 5000 viral clade A, B or C sequences derived from the Los Alamos HIV-1 sequence 
database (www.hiv.lanl.gov), while adjacent amino acid residues were more variable (Figure 3.11B). 
Together, these observations support the notion that the Thr216 residue in HIV-1 RT is susceptible 
to Cdk phosphorylation, and functionally and/or structurally important for HIV-1 replication. 
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  Figure 3.8 MS
2 spectrum of the phosphorylated synthetic peptide [210-227] analyzed 
using MALDI-LTQ-MS. MS2 fragmentation reveals a strong neutral loss of 98 m/z units, 
corresponding to phosphoric acid, characteristic of Ser/Thr phosphorylated peptide ions 
(McLachlin and Chait, 2001). The signals with m/z of the backbone fragmentation indicated 
that the underlined Threonine residue is phosphorylated. b ions indicate N-terminal peptide 
fragments and y’’ ions indicate C-terminal peptide fragments, both with cleavage at the peptide 
bond (Biemann, 1990). Phosphate observed in the y’’11 but not the y’’12 ion indicates the 
phosphate group is on the Threonine in the seventh, not the sixth, position in the sequence, 
which corresponds to Thr216 in the RT sequence.  
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Figure 3.10 MS2 and MS3 spectra of Thr216 [202-220] phosphorylated Lys-C proteolytic RT 
peptide. In MS2 spectrum, a strong neutral loss of phosphoric acid indicated the presence of 
phosphate, and the minor peaks representing backbone fragmentation showed the phosphorylation 
occurs on the underlined Threonine (in the CDK motif). m/z consistent with phosphorylation on 
the b15 ion but not he b14 ion indicates that the phosphate group is on the Threonine at the 15th 
position, which corresponds to Thr216 in the RT sequence. MS3 fragmentation of m/z 2316 (loss of 
phosphate in MS2) confirmed the sequence of phosphorylated peptide, by presenting backbone 
fragmentation consistent with the 202-220 peptide, but without phosphate addition. 
MS2 MS3
Ion m/z Sequence Ion m/z Sequence
b10* 1288.74 IEELRQHLLR b10* 1288.74 IEELRQHLLR
b11* 1474.82 IEELRQHLLRW b11* 1474.82 IEELRQHLLRW
b13* 1644.92 IEELRQHLLRWGL b13* 1644.92 IEELRQHLLRWGL
b14* 1745.97 IEELRQHLLRWGLT b14* 1745.97 IEELRQHLLRWGLT
b15 1847.02 IEELRQHLLRWGLTpT b15* 1767.02 IEELRQHLLRWGLTT
b16 1944.07 IEELRQHLLRWGLTpTP b16* 1864.07 IEELRQHLLRWGLTTP
b17 2059.10 IEELRQHLLRWGLTpTPD b17* 1979.10 IEELRQHLLRWGLTTPD
b18 2187.19 IEELRQHLLRWGLTpTPDK b18* 2107.19 IEELRQHLLRWGLTTPDK
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3.3.3 Substitution of T216 by Alanine reduces HIV-1 RT 
To investigate if the Cdk2-dependent phosphorylation of HIV-1 RT has functional 
implications for HIV-1 reverse transcription, Lichterfeld’s group used site-directed mutagenesis to 
construct a GFP-encoding R5-tropic or VSV-G-pseudotyped HIV-1 variant in which the identified 
phosphorylation position Thr 216 is mutated to Ala (T216A), so that the position could no longer 
be phosphorylated. The replicative activity of the wild-type and the variant virus was assessed in ex-
vivo activated CD4+ T cells. A direct comparison of the replicative activity of the wild-type and the 
variant virus over an 8-day period demonstrated a significantly reduced ability of the variant virus to 
produce HIV-1 p24 antigen, which is consistent with viral fitness (Figure 3.12A). Furthermore, the 
infection of CD4+ T cells with the T216A variant leads to reduced proportions of GFP-positive 
CD4+ T cells in comparison to CD4+ T cells with the wild-type (Figure 3.12B-E). The lower 
replicative activity of the variant virus was associated with reduced levels of early, intermediate and 
late HIV-1 reverse transcripts, suggesting that the phosphorylation residue Thr216 is needed for 
effective reverse transcription. Together, these findings suggest that Cdk2-dependent 
phosphorylation of HIV-1 RT does contribute to viral fitness through modulation of viral reverse 
transcription.  
Figure 3.11 Conservation of Thr 216 in RT. (A): Solvent-exposed position of Thr216 in crystal 
structures of HIV-1 RT. (B): Entropy of amino acid residues at position 214-219 in indicated 
clade A, B and C HIV-1 RT sequences obtained from the Los Alamos HIV-1 sequence database. 
The entropy results are generated by Jin Leng at MGH. (2014 Leng) 
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Figure 3.12 HIV-1 RT T216A mutation decreases HIV-1 reverse transcription (A): HIV-1 p24 
antigen production in the supernatant of activated CD4+ T cells infected with similar titers of R5-
tropic wild-type HIV-1 or the corresponding T216A variant. Data were analyzed by fitting a linear 
model to the log-transformed p24 concentration using maximum likelihood models. Right panel 
demonstrates one representative experiment, left panel summarizes the relative replication 
capacity of wild-type and variant viruses, calculated based on the slope for the p24 production 
curves in n=4 experiments. (B/D): Proportions of CD4+ T cells infected with R5-tropic or VSV-
G-pseudotyped HIV-1 wt and corresponding T216A variants.  (C/E): Quantitative analysis of 
early, intermediate and late HIV-1 RT transcripts in activated CD4+ cells infected with either wild-
type R5-tropic or VSV-G-pseudotyped HIV-1 or the corresponding T216A variants. These results 
are generated by Jin Leng at MGH. (2014 Leng) 
 93 
3.3.4 Quantification of HIV-1 in vitro Cdk2-dependent phosphorylation  
 To comprehend the amount of HIV-1 RT phosphorylated  in vitro, relative stable isotope 
labeling quantification was conducted in conjunction with mass spectrometry. This requires that one 
sample be chemically modified with a heavy, stable isotope-containing chemical group, while the 
second sample be modified with the same chemical group that contains only regular isotopes. The 
two samples are then mixed. Mass spectrometry can distinguish the heavy isotope species from the 
first sample, and the corresponding regular isotope species from the second sample.  The relative 
amounts of that species are then simply obtained from the heavy-to-light peak intensity ratio. In this 
experiment, isotope is introduced as deuterated methyl groups after in-gel proteolysis. Free amines 
from lysine side chains and peptide N-termini are dimethylated either with regular hydrogen-
containing methyl groups (2 x CH3, for the unphosphorylated sample) or with doubly-deuterated 
methyl groups (2 x CD2H, for the phosphorylated sample) (Figure 3.13A). The regular isotope-
labeled unphosphorylated RT peptides are then mixed with the heavy isotope-labeled 
phosphorylated RT peptides, and subjected to MALDI-MS analysis.  
 Relative quantification of T216 phosphorylation is determined by measuring the decrease in 
the abundance of unphosphorylated proteolyic peptide fragment ion spanning residues 202-218.  
Peak intensity of the unphosphorylated T216-containing peptide is decreased for deuterated, Cdk-
treated RT (red bar, m/z = 2091.6) relative to regular, RT with no kinase treatment (blue bar, m/z = 
2087.6) (Figure 3.13B). These measurements are obtained from the b17 fragment ion spanning RT 
residues 202-218 arising from the MS2 fragmentation of Lys-C proteolytic peptide spanning residues 
202-220. The MS2 fragment ions are used to increase specificity and decrease chemical noise. 
Quantitative results are derived as the second isotope after deconvolving the overlapping isotope 
distributions of the H- and D-containing peptides. Similar results are obtained for other, less intense 
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fragment ions of the same parent peptide (not shown). Internal standard spectra (inset) are used to 
correct for potential differences in peptide recovery. By using dimethyl-based stable isotope to 
determine in vitro phosphorylation stoichiometry for the p51 and p66 subunits of HIV-RT, the 
results showed that 92.3% Thr 216 on p51 and 62.1% Thr216 on p66 are phosphorylated in in vitro 
kinase assays (Figure 3.13C). 
 
  
Figure 3.13 Quantification of in vitro phosphorylation of HIV-1 RT by using stable 
isotope labeling in conjunction with mass spectrometry. (A) quantification workflow . 
(B) MS2 mass spectra of mixtures of Cdk untreated and treated HIV-1 samples, labeled by 
regular and deuterated methyl groups. p51 and p66 are two subunits of HIV-1 RT. (C) 
Stoichiometric results for phosphorylation on the p51 and p55 subunits of HIV-1 RT.  
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3.3.5 Cdk2-dependent phosphorylation increases function and stability of HIV-1 RT 
We subsequently determined whether Cdk phosphorylation of HIV-1 RT directly modulates 
the enzymatic activity of reverse transcriptase. For this purpose, HIV-1 RT was exposed to 
Cdk2/cyclin A, which resulted in 92% and 62% phosphorylation of the p51 and p66 RT subunits, 
respectively; unphosphorylated HIV-1 RT was used as a control. Either HIV-1 RT was incubated 
with a poly (A) template, oligo dT primer and dTTP, followed by monitoring of RT activity via the 
formation of RNA-DNA heteroduplexes. These experiments demonstrated an increased enzymatic 
activity of phosphorylated HIV-1 RT, suggesting that Cdk2 phosphorylation supports the functional 
activity of the enzyme (Figure 3.14A).  
Since phosphorylation often influences the stability of proteins (2011 Nishi), we considered 
whether Cdk2 might serve to modulate the resistance of HIV-1 RT to proteolytic degradation.  
Limited proteolysis was employed as an in vitro tool for probing HIV-1 RT stability. Cdk2/cyclin A-
phosphorylated and un-phosphorylated HIV-1 RT was incubated with subtilisin protease - known to 
be sensitive to the three-dimensional conformation of its substrate - at different reaction times 
ranging from 2 min to 4 hr. (Figure 3.14 B/C). These experiments demonstrated a markedly more 
rapid decrease in band intensity for the unphosphorylated HIV-1 RT. Indeed, after 180 minutes of 
exposure to subtilisin, gel densitometry indicated that 45% of the phosphorylated RT, versus only 
20% of the unphosphorylated RT, remained undigested, demonstrating that Cdk2 phosphorylation 
protects HIV-1 RT from protease cleavage. However, CD4+ T cell infection with the viral wt or the 
T216A variant in the presence of proteasome inhibitors resulted in proportionally equal increases in 
HIV-1 replicative activity, suggesting that proteasomal degradation of HIV-1 RT is unaffected by 
Cdk2-dependent RT phosphorylation (1998 Schwartz). Together, these data indicate that Cdk2 
phosphorylation of Thr216 protects HIV-1 RT from protease activity, and suggests that its 
 96 
mechanism of action may be to stabilize HIV-1 RT against intracellular proteases, perhaps via 
conformational modulation. 
 
 
 
 
 
3.3.6 p21 (waf-1/cip-1) suppresses Cdk2-dependent HIV-1 RT phosphorylation. 
The cell-intrinsic Cdk inhibitor p21 (waf-1/cip1) is upregulated in CD4+ T cells from many 
persons with natural control of HIV-1 replication (“elite controllers”) (2011 Chen), raising the 
possibility that p21 has a functional role for inhibiting Cdk2-dependent phosphorylation of reverse 
transcriptase and reducing the efficacy of viral reverse transcription in CD4+ T cells from these 
patients. To investigate this, we first analyzed the subcellular localization of p21 in CD4+ T cells 
from elite controllers, using high-throughput imaging flow cytometry, an approach that combines 
standard flow cytometry with high-resolution fluorescence microscopy. For this purpose, CD4+ T 
cells from elite controllers and HIV-1 negative persons were intracellularly stained with antibodies 
directed against p21, and with the nuclear dye DAPI. This analysis demonstrated that p21 was 
Figure 3.14 Cdk2-dependent phosphorylation enhances activity and stability of HIV-1 RT. 
(A) Assessment of the functional activity of phosphorylated and unphosphorylated HIV-1 RT in a 
cell-free system. One representative experiment out of 4 is shown. (B) SDS-PAGE gel of limited 
proteolysis of unphosphorylated (left) and cyclin A/Cdk2 phosphorylated (right) HIV-1 RT time 
course. Degradation of the p66 and p51 subunits of HIV-1 RT (major upper and lower bands, 
respectively) is shown as a function of time and phosphorylation state. (C) Quantitative 
comparison of the rates of proteolysis for unphosphorylated and phosphorylated HIV-1 RT as 
measured by SDS-PAGE gel densitometry of Sypro Ruby-stained HIV-1 RT. 
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located both in the nuclear and in the cytoplasmic subcellular compartment (Figure 3.15A/B), and 
did not change substantially after in vitro activation. Importantly, we observed that total, nuclear and 
cytoplasmic cell-associated p21 was expressed at significantly higher levels in CD4+ T cells from elite 
controllers compared to HIV-1 negative persons, but differences were more obvious for 
cytoplasmic p21 than for nuclear p21 (Figure 3.15A-B). This suggests that p21 may be functionally 
relevant for inhibiting Cdk2-dependent phosphorylation of HIV-1 reverse transcriptase in the 
cytoplasm of CD4+ T cells from elite controllers. To further investigate this, we analyzed HIV-1 
reverse transcription in CD4+ T cells from elite controllers after electroporation with p21-specific 
siRNA, which resulted in effective reduction of p21 protein expression. We found that following 
infection of CD4+ T cells from elite controllers with either R5-tropic or VSV-G-pseudotyped HIV-
1, siRNA-mediated reduction of p21 expression resulted in enhanced levels of HIV-1 positive cells, 
and in increased levels of viral reverse transcripts. Interestingly, such effects were not visible in 
CD4+ T cells from HIV-1 negative persons, likely due to lower baseline expression of p21 that 
minimizes biological effects of p21 silencing (Figure 3.15C-F). Moreover, p21 knockdown did not 
affect HIV-1 replication in CD4+ T cells from elite controllers infected with the T216A variant, 
supporting the notion that p21 inhibition of HIV-1 reverse transcription depends on 
phosphorylation of Thr216 (Figure 3.15C-F). In addition, we observed that in CD4+ T cells from 
elite controllers, the wild-type virus and the T216A variant showed a similar replicative activity 
(Figure 3.15G/H), which represented a sharp contrast to the replicative advantage of the wild-type 
virus in CD4+ T cells from HIV-1 negative individuals (Figure 3.12B-E); this indicates that the 
increased viral fitness associated with RT phosphorylation at position Thr216 is not visible in cells 
with high-level p21 expression. Finally, we noted that p21 knockdown led to increased levels of 
phosphorylated HIV-1 RT in CD4+ T cells from EC infected with R5-tropic or VSV-G 
pseudotyped HIV-1, providing formal evidence for an inhibitory effect of p21 on Cdk2-dependent 
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RT phosphorylation (Figure 3.15I). p21 silencing also appeared to increase levels of 
unphosphorylated RT, specifically in cells infected with R5-tropic HIV-1 in which p21-mediated 
inhibitory effects on viral replication are amplified during multiple rounds of infection. Taken 
together, these data suggest that high-level p21 expression can indirectly inhibit viral reverse 
transcription through blockade of Cdk2-dependent phosphorylation of viral RT.  
 
 
 
 
 
 
 
  
Figure 3.15 Inhibition of p21 (waf-1/cip-1) Increases HIV-1 Reverse Transcription in CD4+ T Cells 
from Elite Controllers. (A): Analysis of the subcellular localization of p21 in CD4+ T cells. PBMCs from 
Elite controllers or HIV-1 negative patients were stained with antibodies against CD4 (yellow pseudocolor), 
p21 (green pseudocolor) and DAPI (red pseudocolor) and subjected to ImageStream analysis. Selected 
images of single-cell analysis plots from an HIV-1 elite controller and an HIV-1 negative patient are shown. 
(B): Cumulative average p21 signal intensity in CD4+ T cells from Elite controllers (n=6) and HIV-1 
negative persons (n=6) in total, cytoplasmic and nuclear compartments of CD4+ T cells. (C/D): Proportion 
of HIV-1 positive CD4+ T cells from EC and HIV-1 negative persons after ex-vivo infection with R5-tropic 
or VSV-G-pseudotyped HIV-1 in the presence of siRNA-mediated knock-down of p21. TheT216A variant 
virus was used where indicated.  (E/F): Corresponding analysis of early, intermediate and late RT transcripts 
in elite controllers. (G-H): Comparison of HIV-1 replication patterns of wild-type HIV-1 and the T216A 
variant in CD4+ T cells from EC. (G) demonstrates proportion of infected CD4+ T cells, (H) reflects levels 
of early, intermediate and late reverse transcripts. (I): HIV-1 RT phosphorylation in CD4+ T cells after 
experimental p21 knock-down. CD4+ T cells were transfected with siRNA directed against p21 or control 
siRNA, infected with R5-tropic or VSV-G pseudotyped HIV-1 and hybridized with antibody against HIV-1 
RT, anti-[phospho-210-227] RT or b-actin. These results are generated by Jin Leng at MGH. (2014 Leng) 
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3.4 Discussions and Conclusion 
Human Cdks have shown its ability to phosphorylate a wide range of host substrates in vitro 
or in vivo, and the phosphorylation events significantly contribute to numerous biological functions, 
including regulation of cell proliferation, survival, differentiation, motility, and gene expression.  In 
addition to cellular regulation, Cdks also play a recognized role in virus-infected cells for regulation, 
replication, and maintenance of viral functions, such as transcriptional elongation, RNA initiation 
and processing (2008 Durand, 2010 Zydek). In HIV-1 infection, the host Cdks have been mostly 
suggested to regulate the post-integration stage of HIV-1.  For example, HIV-1 transcription 
elongation depends on the interaction of HIV-1 Tat with host Cdks.  HIV-1 RNA polymerase II is 
phosphorylated by Cdk9 whose activity is in turn stimulated by Tat phosphorylation catalyzed by 
Cdk2 (1999 Flores, 2006 Ammosova) However, a possible impact of Cdks on viral pre-integration 
steps has remained unknown. In this study, we examined whether Cdk2 specifically phosphorylates 
HIV-1 RT, and whether Cdk2 phosphorylation of RT has regulatory effect on HIV-1 reverse 
transcription during HIV-1 pre-integration. Our data indicate Cdk2 phosphorylation of RT on Thr 
216 facilitates HIV-1 reverse transcription, supporting the emerging recognition of host kinases as 
modulators of HIV-1 replication in human CD4+ T cells where HIV-1 virus exploits the virus-host 
interaction on their own purpose for viral propagation as well as survival in human cells.  
Considering that Cdk2 has only in vitro phosphorylated the Cdk motif containing Thr 216 
among the 7 Cdk consensus motifs of HIV-1 RT in the absence of Cks, therefore we suspect that 
Cdk2 might phosphorylate other motifs later after its activity is stimulated by Cks binding with the 
phosphorylated Thr216. Although the role of Cks in the control of cell cycle is still elusive, it has 
been previously demonstrated that the Cks associate with Cdk-cyclin complexes, modulate their 
phosphorylation ability, and target the Cdks to phosphorylated substrates in multisite 
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phosphorylation (1996 Pines, 1999 Patra); for instance, Sic1 multisite phosphorylation is stimulated 
in the presence of Cks, but the stimulatory effect requires that T5 and T33 of Sic1 are 
phosphorylated as Cks binding sites (2011 Koivomagi, 2013 Koivomagi). In another study, Cks 
showed no promotional effect on Wee1 hyperphosphorylation by Cdk1, yet Cks binds to the 
phosphorylated Cks consensus sites and induce inhibitory phosphorylation in Cdk1 by 
phosphorylated Wee1, when the Cks consensus sites on Wee1 are phosphorylated in late 
phosphorylation (2013 McGrath). It remains an open question whether the Cdk motif containing 
T216 also acts as a Cks-binding consensus site, and it will be interesting to explore conservation of 
the other Cdk phosphorylation motifs of RT and the role of multisite phosphorylation in HIV-1 
infection in which Cks contributes to the phosphorylation process. 
How might HIV-1 RT benefit from Cdk phosphorylation? The addition of phosphate might 
cause conformational and functional changes in RT. The HIV-1 RT is a heterodimer comprised of 
two separate subunits, referred to as p66 (~ 66kDa) and p51 (~ 51 kDa); the p51 subunit is 
processed by proteolytic cleavage of the p66 subunit by the viral-encoded protease. Although p66 
and p51 have identical amino acid sequences (first 440 amino acid), they are functionally and 
structurally distinct. The p66 subunit contains active sites as an executer of RT functions with the 
p51 subunit stabilizing the complex and facilitating RNA/DNA bybrid positioning (2013 Chung), 
whereas the functional role of p51 subunit remains elusive. According to the quantitative data, 
62.1% and 92.3% Thr 261 on p66 and p51 of RT is phosphorylated in vitro, respectively, suggesting 
the Cdk2 phosphorylation may contribute to modulation of the enzymatic activity and stability of 
RT and thus results in the enhanced HIV-1 fitness. In agreement with this, the later results showed 
Cdk2 phosphorylation indeed increases function and stability of HIV-1 RT.  
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An unresolved issue here is that how the Cdk2 dependent phosphorylation can affect HIV-1 
reverse transcription during the viral pre-integration stage on the molecular basis of functional and 
conformational changes of the complex. With regard to phosphorylation on the catalytic subunit, it 
seems to interesting that the highly conserved phosphorylation site, Thr 216 residue, is in immediate 
proximity to the hot spots of RT amino acid residues at Thr 215 and Lys 219 of p66 subunit with 
known roles for influencing incorporation of nucleotides into viral DNA (2002 Chamberlain, 2010 
Tu). Their mutations (T215Y or F, and K219Q) render RT resistant to nucleoside analogue 
inhibitor, 3’-azido-3’-deoxythymidine (AZT) (Jacobo-Molina, 1991 Biochemistry), suggesting that 
the two residues are associated with the formation of the triphosphate binding site in HIV-1 
transcription in the p66 subunit. In line with this, the triphosphate binding may potentially assist 
Cdk2 transfers the terminal phosphate from ATP to Thr 216 phosphorylation site during 
phosphorylation. Moreover, the p51 subunit of RT has been observed being enzymatically inactive 
because of the alternative configuration and the absence of a C-terminal ribonuclease H (RNase H) 
domain, but it has a structurally stabilizing contribution to facilitating p66 loading onto nucleic (1998 
Harris) and hybrid RNA/DNA binding and orienting the RNA strand for hydrolysis in the p66 
RNase H active site (2013 Chung). Prior studies demonstrated that host ERK/MAPK family kinases 
could enhance chromosomal HIV-1 integration through the induction of phosphorylation-induced 
conformational changes in HIV-1 integrase (2013 Manganaro). Similarly, phosphorylation of the p51 
subunit may play a role in establishing or stabilizing particular conformations of RT by forming 
more hydrogen bonds, providing structural support.  
Because increasing evidence showed that the host Cdk inhibitor p21, a protein best known 
as cancer suppressor, seems to retain its ability to suppress HIV-1 replication, p21 has received 
much attention in the context of HIV-1 infection. Intensive studies over the past few years 
highlighted the p21 is capable of modulating the efficacy of HIV-1 replication in human 
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macrophages (2009 Bergamaschi), hematopoietic stem cells (2007 Zhang), and CD4+ T cells (2011 
Chen), although it seems likely to have different underlying mechanisms associated with HIV-1 
restriction in each cell population. In macrophages, p21 was found to inhibit HIV-1 replication by 
blocking dNTP biosynthesis via down-regulating the expression of RNR2 (ribonucleotide reductase 
subunit R2), an essential enzyme for the reduction of ribonucleotides to dNTP (2009 Bergamaschi). 
In hematopoietic stem cells, inhibition of HIV-1 integration by p21 was observed, while HIV-1 
reverse transcripts stay unaffected (2007 Zhang). Interestingly, previous findings suggest that 
selective upregulation of the p21 proteins occurs in activated primary CD4+ T cells of HIV-1 elite 
controllers, inhibiting transcriptional elongation of HIV-1 mRNA and HIV-1 reverse transcription. 
The evidence showed that HIV-1 mRNA transcription affected by p21 was, at least in part, through 
the indirect blockade of enzymatic activity of a host enzyme Cdk9, known to phosphorylate RNA 
polymerase II for enhancing HIV-1 mRNA elongation. However, it was not clear how p21 affects 
HIV-1 reverse transcription during pre-integration stage. Our in vitro and in vivo data in this study 
conclusively demonstrate a role of p21 for a cell-intrinsic mechanism underlying the inhibition of 
HIV-1 reverse transcription in CD4+ T cells from elite controllers by blocking phosphorylation of a 
host enzyme Cdk2, shown its ability to phosphorylate HIV-1 reverse transcription on a highly 
conserved residue Thr 216. Taken together, the cell-intrinsic inhibitor p21 shows two distinct 
pathways of indirect suppression of HIV-1 infection at HIV-1 replication steps – mRNA elongation 
and reverse transcription by indirectly interacting human host cells. Although the indirect inhibition 
of p21 appears to be less effective than the inhibition of traditional pharmacological RT inhibitors 
by interacting directly with HIV-1 gene products, but the indirect mechanism can more possibly 
prevent viral mutational escape, a major cause of drug resistance. This might explain why no 
selection of viral escape variants of HIV-1 infected lymphocytic and monocytic cells in the presence 
of pharmaceutical Cdk inhibitors was observed in ex vivo cultures (2001 Wang).  
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As for the mechanism of host cell control against HIV-1, these data provide very useful 
insight into an cell-intrinsic immune defense mechanism in CD4+ T cells from elite controllers, 
where Cdk2 phosphorylation of HIV-1 RT, an essential modification for enhancing efficiency of 
HIV-1 reverse transcriptase, is inhibited by highly unregulated p21 proteins. Interestingly, a recent 
report showed that p21 also regulates the HIV-1 restriction factor by inhibiting Cdk1-mediated 
phosphorylation of SAMHD1 into an active form with its ability to restrict HIV-1 during reverse 
transcription in macrophages (2014 Pauls). The findings suggest that p21 appears to act as a master 
of regulator controlling HIV-1 infection in different HIV-1 replication steps by indirect interaction 
with viral proteins. Of many immune responses to HIV-1 infection, the majority of data suggested 
the emergence of HIV-specific CD4+ and CD8+ T-cells are correlated to a decline in HIV viral loads 
as a result of immune protection (2010 Streeck, 1999 Jin, 1999 Schmitz, 1994 Koup, 1994 Borrow). 
However, further data revealed that effective T cell responses are not always necessary for long-term 
virus control of HIV-1 infection (2011 Chen, 2011 Jager, 2008 Emu, 1998 Martin). Many HIV-1 
elite controllers are, for example, capable of maintaining normal CD4+ T-cell counts and 
undetectable levels of HIV-1 replication over very long follow-up periods in the absence of strong 
HIV-1-specific CD8+ T cells (2008 Emu). Overall, although different mechanism may act together 
or specifically in HIV-1 infected individuals in the synergistic networks among host proteins, viral 
proteins and the CD8+ T cell-mediated adaptive immunity, it can be speculated at the moment that 
the cell-intrinsic inhibition of Cdk phosphorylation by p21 may provide a clue to induce a long-term, 
drug-free remission or a functional cure of HIV-1 infection (2014 Leng). 
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Chapter 4: Summary and Future Directions 
This thesis contributes to developing MALDI mass spectrometric methods without 
expensive isotope labels and time-consuming calibration curves for single- and double-site 
phosphopeptide quantification in in vitro assays (chapter 2). Through mass spectrometric techniques, 
Cdk2 phosphorylation of HIV-1 reverse transcriptase at a specific site (Thr 216) has been 
successfully identified that reveals a cell-intrinsic mechanism of inhibition of HIV-1 reverse 
transcription with demonstration of in vivo experiments (chapter 3). 
Chapter 2.2 described the results of the DRIP-Q method development and indicated that it 
may be worthwhile to utilize label-free and calibration-curve-free MALDI-MS as an easy-to-use and 
robust alternative approach to quantifying phosphopeptides for three different peptide models 
encompassing phosphoserine, phosphothreonine and phosphotyrosine, and further may be applied 
in in vitro assays, such as for testing drug efficacy. The method is not limited by the difference in 
MALDI laser energy provided by different MALDI instrument, because the results showed that the 
change in laser energies of MALDI does not affect the feasibility of the method if the same energy is 
controlled in one set of experiments. The results obtained demonstrated that the DRIP-Q method 
provides a wide dynamic range of at least two orders of magnitude and a good reproducibility of 
inter-day CV of 0.65 % (n=3). The method was further validated by comparing with an isotope 
dilution method that most quantification of phosphorylation relies on, showing the two methods are 
comparable with excellent accuracy, and by assessing the in vitro inhibition of Cdks, showing IC50 
values of pharmaceutical Cdk inhibitors consistent with the literature. 
Although the DRIP-Q method demonstrated its feasibility in in vitro assay, the analytical 
performance of the DRIP-Q method will need to be challenged by performing phosphorylation 
analysis in more complex sample systems, such as peptide digests from purified phosphoporteins. 
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For example, it would be interesting to synthesize the unphosphoryltaed and phosphorylated trypic 
HIV-1 RT peptides containing the identified phosphorylation site Thr216 for probing 
phosphorylation quantification of HIV-1 RT protein phosphorylation by using the DRIP-Q 
method. 
In addition, the method can be further refined and expanded into analysis of a larger number 
of peptides (In this study, there are only three peptides, one each with pSer, pThr, and pTyr). For 
example, a systematic peptide sequences with different number of basic or acidic residues can be 
subjected to the proposed DRIP-Q method for testing its general feasibility. The 
peptide/phosphopeptide samples can also be assigned to different laboratories, and the results from 
the inter-labs can compared to evaluate the performance of the DRIP-Q method. 
Chapter 2.3 proposed another label-free, calibration curve-free method by using tandem 
mass spectrometric technique for quantification of the double-site phosphorylation of AQP2. This 
new method overcomes the difficulty in traditional MALDI-MS analysis of two distinct singly 
phosphorylated peptides with an identical mass. With the use of economical CID-MS3, the method 
provides an efficient way to quantify singly AQP2 phosphopeptides at each of two discrete 
phosphorylation sites (Ser-256 and Ser-261) by measuring the change in the intensity ratios of the 
MS3 fragments in response to the amounts of pSer-256 and pSer-261 in a sample mixture. The 
results successfully demonstrated two assumptions that support the mathematic approach used in 
the method: (1) the relative MS3 fragment intensities of individual phosphopeptide (α for pSer-256 
and β for pSer-261) remain constant while the amount of the phosphopeptide changes; and (2) MS3 
signal responses are directly proportional to sample concentrations. It has been observed that the 
change in collision energy may affect the values of α and β, but does not affect the feasibility of the 
method by providing the same collision energy to all samples in an experiment. The data suggest 
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that the method provides a wide dynamic range of at least 3 orders of magnitude and good accuracy 
with comparable results to the traditional calibration curve method. The method was further 
effectively applied to an in vitro kinase assay to measure the change of the phosphorylation at Ser-256 
and Ser-261 of AQP2 in the presence of both PKA and Cdk1/Cyclin B.  
One of the important future extensions of the work involves application of in vitro kinase 
assays by assessing AQP2 double-site phosphorylation in the presence of two different kinases. In 
this study, we observed an increase of pSer-261 at a high level of Cdks. However, insufficient 
consideration given to this method is that the production of doubly phosphoAQP2 peptides can 
lead to an unpredictable decrease in the absolute amount of singly phospho- and 
unphosphopeptides. In order to accurately quantify the total absolute amount of single 
phosphorylation of AQP2 by PKA or Cdk1 in an in vitro kinase assay, there is a need to obtain 
standards of doubly phosphoAQP2 peptides on Ser-251 and Ser-261. A peak of doubly 
phosphoAQP2 will be observed on a MS full scan spectrum with a mass shift of two-phosphate-
addition from the unphosphoAQP2 peptide. The amount of occurring double phosphorylation can 
then readily measured by monitoring the change in signal intensity of the peak of doubly 
phosphoAQP2 in a sample, compared to the standard. Therefore, the proposed method is able to 
quantify singly phosphopeptides on the sites Ser-256 or Ser-261 with consideration of the double 
phosphorylation event. A further extension of this methodology will be to apply it to 
phosphoprotein digests, to quantify double-site phosphorylation in the context of a whole protein. 
Chapter 3 revealed a cell-intrinsic mechanism of blocking HIV-1 reverse transcription by 
discovery of Cdk2 phosphorylation site at a highly conserved Thr 216 of HIV-1 RT. After assessing 
phosphorylation of the HIV-1 RT protein using a variety of Cdk kinases in an in vitro kinase assay, 
the results show that Cdk2 imparts Cdk- and site consensus- specificity to RT phosphorylation. The 
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host Cdk2 kinase does not only phosphorylate HVI-1 RT protein but also supports HIV-1 reverse 
transcription. Site-directed mutagenesis experiments was conducted based on substitution of Thr 
216 by Ala, demonstrating the vital contribution of the Cdk2-dependent phosphorylation of RT to 
viral fitness through modulation of viral reverse transcription. In the in vitro phosphorylation assay, 
the results of dimethyl-based stable isotope quantification showed that 92% Thr261 on p51 subunit 
of RT and 62.1% Thr216 on p66 subunit of RT are phosphorylated. The in vitro phosphorylated RT 
was then subjected to an enzymatic activity assay and limited proteolytic experiments, suggesting 
Cdk2 phosphorylation does increase the functional activity and stability of HIV-1 RT. Further p21 
knockdown experiments provide strong evidence that the intrinsic Cdk inhibitor, p21, can indirectly 
inhibit HIV-1 reverse transcription and reduce the efficacy of viral transcription in CD4+ T cells 
from elite controllers by blocking Cdk2 phosphorylation of RT. 
However, there are several particular questions to the proposed cell-intrinsic mechanism: (1) 
What does Cdk2 phosphorylation affect a conformational change of the RT protein? (2) Whether 
Cks1 can be involved the proposed mechanism by which the Cks1 protein may modulate 
processivity of Cdk2/CyclinA? And (3) How do Cdk kinases associate with other viral HIV-1 Cdk 
phosphorylation substrates, leading to a change in HIV-1 viral replication?  
As mentioned above in Chapter 3, the RT protein was shown to be phosphorylated at the 
two subunits, p66 and p51, known as to have a functional role and structural role, respectively. The 
Cdk2 phosphorylation site is situated near the interface between fingers and palm subdomain of the 
RT structure. It has been reported that, for the p66 subunit, the palm subdomain accommodates the 
enzymatic active site; the finger subdomain stabilizes the RNA template; the thumb subdomain 
interacts with the DNA strand (2014 Nowak), and the p51 subunit stabilized RT heterodimer 
structure that is required for its function (2005 Depollier). In this study, the addition of a phosphate 
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group during Cdk2 phosphorylation may result in a significant conformational change associated 
interaction with RNA template as well as the DNA strand, and dimerization of the two subunits, 
and consequently cause the change in enzymatic activity of RT. 
In addition, it is interesting to consider that experiments assessing Cdk2 phosphorylation in 
the presence of Cks1 to investigate the intriguing role of Cks1 in the RT phosphorylation. The 
phosphorylated Thr216 site might also be a Cks1 consensus site containing the Cdk-acceptor site 
(TP) and a bulky hydrophobic residue Tryptophan in the -3 position that facilitates binding of Cks1 
to phospho216-Cks1. In this study, the in vitro kinase assay performed in the absence of the Cks1 
protein might have underestimated the other potential phosphorylation sites that may be induced by 
Cks1. Considering the western-blotting data cannot give a clue because the data were obtained by 
probing Cdk2 phosphorylation with only Thr216 specific antibodies; therefore the Cks1 study will 
be one of the important future directions for better understanding of the cell-intrinsic mechanism. 
One more future work will be aimed at characterization of any potential phosphorylation 
sites on other viral proteins. The pharmaceutical Cdk inhibitors were consistently observed to inhibit 
HIV-1 replication with no selection of viral escape variants in the infected lymphocytic and 
monocytic cells (2001 Wang). In addition, another cell-intrinsic mechanism of HIV-1 restriction 
associated with the Cdk inhibitor p21 was recently discovered that p21 acts as a negative regulatory 
master to reduce HIV-1 reverse transcription through blocking Cdk1-mediated phosphorylation of a 
restriction factor SAMHD1. Altogether, Cdk phosphorylation appears to be essential for HIV-1 
virus to harnesses host machinery to replicate. In order to comprehend the whole complex Cdk 
phosphorylation network in HIV-1 replication, it would be necessary to identify other potential 
phosphorylation sites on the entire HIV viral proteins by using similar strategies to this research in 
the future studies. The deeper exploration of the role of phosphorylation in HIV-1 replication may 
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offer long term potential for development of prophylactic or therapeutic strategies for HIV-1 
patients. 
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